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Abstract 
 
Binuclear Metallohydrolases (BMHs) are a vast family of enzymes that play crucial roles in numerous 
metabolic pathways. The overarching aim of this thesis is the investigation of the structure and 
mechanism of a series of related BMHs, with a range of physicochemical techniques, in order to 
provide essential insight into the development of specific inhibitors. Since an increasing number of 
BMHs have become targets for chemotherapeutic agents, such inhibitors may thus serve as suitable 
leads in drug development.  
  
The general biochemical properties of BMHs is discussed in Chapter 1. Particular focus is on 
antibiotic-degrading metallo-β-lactamases (MBLs), Zn2+-dependent enzymes that have emerged as a 
major threat to global health care due to their ability to inactivate most of the commonly used 
antibiotics. No clinically relevant inhibitors for these enzymes are currently available, exacerbating 
their negative impact on the treatment of infections. Also discussed are a range of phosphatases; while 
functionally distinct from MBLs, they employ a related mechanistic strategy to hydrolyse a broad 
range of phosphorylated substrates. Specifically, purple acid phosphatases (PAPs) are also a useful 
target for novel chemotherapeutics to treat osteoporosis, while organophosphate (OP) pesticide-
degrading enzymes have gained attention as biocatalysts for application in environmental 
remediation.   
     
In Chapter 2 the trajectory and transition state of the PAP-catalysed reaction is investigated using a 
high-resolution crystal structure. Importantly, the inhibitor and substrate mimic phosphate is observed 
in two alternative conformations. When superimposed they describe a trigonal bipyramidal structure 
reminiscent of the proposed transition state. Hence, this study provides the first crystallographic 
insight into the transition state of a BMH-catalysed reaction and may thus guide transition state-based 
inhibitor designs.  
  
In Chapter 3 the crystal structure of a fluoride-inhibited OP-degrading BMH, the OP-degrading 
enzyme from Agrobacterium radiobacter (OpdA) is described. The significance of this structure is 
that it highlights the significance of hydrogen bonding interactions in enhancing minor structural 
changes into significant functional differences. Specifically, we demonstrate that in the absence of 
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this hydrogen bond fluoride has no effect on enzyme performance, and illustrate that fluoride binding 
mediates long range effects that influence substrate binding and thus catalytic efficiency. 
   
In Chapter 4 the crystal structures of two novel MBLs from the non-pathogenic marine 
microorganisms Novosphingobium pentaromativorans and Simiduia agarivorans (i.e. Maynooth 
ImiPenemase -1 and -2 (MIM-1 and MIM-2), respectively) are described. These enzymes were 
discovered in a database mining study and highlight that antibiotic-degrading activity is present in 
environments that are not specifically challenged by human activities. Both MIM-1 and MIM-2 are 
efficient MBLs, but are also acting as quorum-sensing enzymes by hydrolysing a range of lactone 
substrates. Their crystal structures demonstrate that the MBL active site can accommodate a range of 
diverse substrates. This observation may render the design of potent inhibitors more difficult as the 
active site may be flexible and/or too ill-defined to interact with a persistent and specific inhibitor. 
  
In Chapter 5 the structural and functional flexibility of the MBL active site was further investigated 
with a range of kinetic and spectroscopic techniques. The focus of this study, Adelaide ImiPenemase 
1 (AIM-1), is a pathogenic MBL isolated from Pseudomonas aeruginosa. The enzyme has two 
distinct options available for the hydrolysis of β-lactam substrates, distinguished by the identitiy of 
the rate-limiting step. This observation supports a model whereby the initial conformation of the 
bound substrate is rather flexible, thus providing an opportunity for the reaction to proceed in two 
alternative pathways. This flexibility may indeed be a useful strategy for the enzyme to remain 
dynamic with respect to its evolution. In essence, due to this flexibility AIM-1 may adapt to novel 
substrates quickly, exacerbating its role in spreading antibiotic resistance. 
  
In Chapters 2 to 5 physico-chemical and structural properties of BMHs with diverse functions and 
substrate preferences have been discussed. In Chapter 6 it is demonstrated that the in-solution 
structures of a selection of BMHs (representing both phosphatases and MBLs) are indeed rather 
conserved. Specifically, the use of magnetic circular dichroism (MCD) is a simple and informative 
technique to probe the coordination environments of BMHs. In Chapter 6 we utilise this technique to 
investigate CpsB, an emerging target for novel agents to combat antibiotic resistance, and the MBL-
like proteins LRA-8, MIM-1 and MIM-2. All of which originate from environmental bacteria that are 
not associated with human disease (the crystal structures of MIM-1 and MIM-2 were described in 
Chapter 4). Co2+ was used as a paramagnetic probe for these MCD studies, facilitating a detailed 
comparison to related BMH and model systems. The spectroscopic data indicate that despite 
considerable functional/metabolic differences, numerous BMHs share close active site structural 
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similarity. Thus, the active site characteristic of numerous BMHs is characterised by functional 
plasticity that may allow at least some of these enzymes (i.e. MBLs) to adopt novel functions rapidly.  
  
In summary, insights gained from this thesis may inform the design and development of potent 
inhibitors for BMHs that can be used as leads for novel chemotherapeutic strategies. Failure to do so 
in the near future presents grave dangers for the future of human health and the treatment of many 
human ailments. In Chapter 7 some recent initial studies are introduced which demonstrate several 
potent MBL inhibitors that are active against representatives from each of the three main groups of 
MBLs (i.e. the B1-, B2- and B3-subgroups). The study was also expanded to include preliminary data 
of a novel MBL-like enzyme from Salmonella typhimurium. The hope is that with further studies like 
the one presented in this thesis, will lead to positive outcomes for healthcare leading into the future.   
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Chapter 1 
 Introduction 
1.1 Bimetallic metallohydrolases  
Bimetallic metallohydrolases (BMH) are a large group of enzymes that are characterised by an active 
site that contains divalent metal ions (≤4 Å apart) that play a pivotal role in the hydrolysis of ester 
and amide bonds of a range of substrates (1,2). While diverse BMHs may vary greatly in their 
polypeptide sequence and biological functions, their active site geometries tend to be rather conserved 
(Figure 1.1). A typical active site geometry for theses enzymes include two divalent metal ions that 
are mainly coordinated by nitrogen atoms from histidine residues, or oxygens from aspartates. The 
coordination spheres generally also contain several water/hydroxide molecules in terminal and/or 
metal ion-bridging positions. The majority of BMHs utilise metal ion-bound hydroxides as 
nucleophiles to initiate the hydrolytic reaction. Several examples of active sites of BMHs are shown 
in Figure 1.1. In the case of the β-lactam antibiotic-degrading metallo-β-lactamases (MBL; for 
illustration a member from the B3 subgroup was selected - see below for more details) the two Zn2+ 
ions in the active site are bridged by the nucleophilic hydroxide (3). In purple acid phosphatase (PAP), 
the only BMH where the necessity for a heterobinuclear metal centre of the form Fe3+-M2+ (with M 
= Fe, Zn or Mn) has been established, the two metal ions are also bridged by a hydroxide in addition 
to an oxygen from an aspartate residue. The hydroxide may also act as reaction-initiating nucleophile 
in PAP, but other candidates are possible, depending on the metal ion composition and substrate used 
in the reaction (4). In some organophosphate (OP)-degrading BMH, including the enzyme from 
Agrobacterium radiobacter (OpdA), the metal ion-bridging hydroxide acts as nucleophile, while a 
carboxylated lysine residue stabilises the active site structure (5). In contrast to MBL or PAP, OpdA 
and related enzymes are rather promiscuous with respect to metal ions they require to promote 
catalytic activity. 
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Figure 1.1: Active site geometries of selected BMHs, all relevant to this thesis. They include MBLs (top left), PAPs (top 
right) and OpdA (bottom) (6-9). 
BMHs play important roles in numerous metabolic pathways and an increasing number of these 
enzymes have become important in the development of chemotherapeutics to treat various human 
ailments. MBLs, for instance, are major contributors to the emergence and spread of antibiotic 
resistance, but to date no clinically relevant inhibitors have been developed to combat their activity 
(10,11). In contrast, OP-degrading BMHs have a strong potential to be used in bioremediation 
applications. OpdA is commercially sold by Orica as an agent that is efficient in breaking down 
pesticides in agricultural areas (12).  
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1.2 Selection and function of metals in BMHs 
In general, the function of metals in enzymes can be structural, catalytic or both. In addition, metal 
ions may provide suitable binding partners for substrate molecules. The selection of metal ions may 
vary between different BMHs, with some of these enzymes displaying a stringent requirement for a 
particular metal ion (e.g. urease for Ni2+) (13,14) while others are far more promiscuous (e.g. OP-
degrading BMHs) (12). Furthermore, some BMHs such as MBLs appear to require Zn2+ in vivo, 
however, in vitro activity can be reconstituted with a range of other divalent metal ions (15). Such 
metal ion replacements are frequently exploited in functional studies where the catalytic and 
spectroscopic properties of different metal ion derivatives of an enzyme are compared to probe its 
mechanism of action. In this thesis, I will employ this methodology to investigate the mechanism of 
MBLs. 
 
All the enzyme systems studied in this thesis (i.e. MBL, PAP, OpdA) are active in the presence of 
Zn2+. Zinc is essential for the growth and development of most forms of life on earth. It is the second 
most prevalent metal (second only to iron) in the human body and is essential to numerous biological 
functions, often associated with proteins. Unlike other first row transition metal ions Zn2+ is unique 
in that it contains a full d orbital (d10) and as such it is diamagnetic. Zn is able to form tetrahedral, 
octahedral or trigonal bipyramidal complexes, with the latter being the most common geometry found 
in metalloenzymes (3). The most common ligands in proteins are histidine residues (16-19).  
1.3 Mechanisms of hydrolysis 
The exact molecular details of the mechanism employed by BMHs can be quite diverse between 
different groups of enzymes, and sometimes even within the same group. For example, for PAPs it 
could be shown that the identity of the reaction-initiating nucleophile may change as a function of the 
metal ion composition of the active site, the pH of the reaction and the identity of the substrates (20,21). 
Similar observations were reported for the OP-degrading BMHs OpdA and 
glycerophosphatediesterase from Enterobacter aerogenes (GpdQ) (22,23). With respect to MBLs 
mechanistic variations are reported within different subgroups, and even within a particular enzyme 
it appears that more than one mechanistic strategy may be available (see below for more details). This 
mechanistic flexibility may also be associated with a functional promiscuity frequently observed with 
BMHs; indeed, it has been speculated that the incorporation of alternative metal ions may serve as 
evolutionary triggers to adapt enzymes for new functions (24). As an example, two recently discovered 
MBL-like enzymes from the marine organisms Novosphingobium pentaromativorans and Simiduia 
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agarivorans, MIM-1 and MIM-2, respectively, are introduced here. The two enzymes were 
discovered due to their sequence homology to known members of the MBL family (25). Indeed, both 
enzymes emerged as potent β-lactam antibiotic-degrading enzymes (26), but they were equally 
efficient as enzymes in quorum-sensing networks, potentially with Zn2+ favouring the lactamase 
activity and Ca2+ the quorum sensing-related one (26). However, despite variations in the details of the 
mechanism employed common to the large majority of BMH is that a metal ion-activated hydroxide 
initiates the catalytic reaction. Figure 1.2 illustrates this principle with a few specific examples.  
 
 
Figure 1.2: Simplified mechanism of selected metallohydrolases (1). 
1.4 Phosphatases 
Phosphatases constitute a large family of enzymes that play crucial roles in numerous metabolic 
pathways, including energy conversion, signalling and DNA replication (27). Many of these 
phosphatases are metal ion-dependent. While phosphatases are capable of hydrolysing the phosphate 
ester bonds of a large array of biologically relevant molecules, some of these enzymes are also 
efficient in catalysing the hydrolysis of synthetic (i.e. non-natural) organophosphates (OPs). Such 
OPs have become widely utilised as plasticizers and pesticides, while others are used as nerve agents 
in chemical and biological warfare (28,29). Especially their use as pesticides is of utmost relevance to 
the global bio economy as they guarantee an expansion of agricultural food production to provide 
sufficient food for a rapidly growing population. However, the use of OPs as pesticides has not been 
without risk. Due to their significant toxicity they pose a serious threat to environmental health, and 
due to their chemical stability they can persist and accumulate in ground water (30,31). If not monitored 
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and controlled properly these pesticides may enter the drinking water and it is thus no surprise that 
the estimated death toll associated with their ingestion is estimated in the hundreds of thousands, 
largely in the developing world (32). The toxicity of these OP pesticides originates from their potent 
inhibition of the enzyme acetyl cholinesterase in the nervous system (33). A recent report from the 
United Nations states that pesticides “impose substantial costs on Governments and have catastrophic 
impacts on the environment, human health and society as a whole”, yet industry (an estimated 50bn 
net worth in 2017) continue to argue that pesticides are required to “feed a growing world” (34). 
Fortuitously, some soil-dwelling microorganisms have evolved the enzymatic machinery to degrade 
such organophosphates; these OP-degrading phosphatases thus provide a promising avenue to 
develop a biocatalytic tool to control pesticide levels and destroy them in an efficient yet “green and 
clean” way (35-41). OpdA, mentioned above, is one of the most efficient OP-degrading enzymes. I will 
elaborate further on this enzyme in Chapter 3. In Figure 1.3 several OP pesticides and nerve agents 
are shown; also included are two OP substrates that are frequently used as convenient substrates for 
functional studies on phosphatases, i.e. the monoester para-nitrophenyl phosphate (pNPP) and its 
diester homolog bispNPP. 
 
Synthetic OPs used in agriculture or warfare are mainly phosphotriesters and enzymes such as OpdA 
evolved to be rather specific for such substrates (12). However, other phosphatases have evolved to 
hydrolyse the P-O bonds of mono-, or diester substrates. Examples of predominantly monoester 
phosphatases include PAPs (42-47) and CpsB from S. pneumoniae (48,49). PAP and CpsB will be 
discussed in more detail in Chapters 2 and 6, respectively. The enzyme GpdQ from E. aerogenes (50), 
mentioned above is predominantly a diesterase, but it demonstrates considerable promiscuity by being 
capable of hydrolysing a range of tri- and monoester substrates as well (23,51).  
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Figure 1.3: Select phosphate ester substrates; A- soman, B- sarin, C- paraoxon, D- bis(p-nitrophenyl)phosphate, E- 
parathion, F- p-nitrophenylphosphate (1). 
Common to the mono-, di- and triesterases introduced above is that they contain a bimetallic metal 
centre in their catalytically active site. The only potential variant may be the enzyme CpsB, which, 
according its crystal structure, may use three closely spaced metal ions to maintain its catalytic 
function (Figure 1.4). However, as will be discussed in Chapter 6, only two of these metal ions play 
an active role in CpsB, while the third metal (M3 in Figure 1.4) represents an artefact of the 
crystallisation procedure. 
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Figure 1.4: Active site of CpsB based on crystallographic studies shows three metal ions bound in the active site (52).  
1.5 Antibiotic-degrading enzymes – Is the age of antibiotics coming to an end? Current 
trends in resistance 
While this thesis focuses on the function and mechanism of a series of BMHs that differ in their 
substrate preference the group that has attracted the most significant attention in recent years is the 
one that comprises the β-lactam antibiotic-degrading MBLs. The reason why these enzymes have 
gained notoriety is outlined in the remaining sections of this introduction. Before the discovery of the 
β-lactam penicillin by Alexander Fleming in the 1920’s a simple prick from a rose thorn could lead 
to a potentially lethal infection (52). Since the introduction of penicillin and its various derivatives 
(which constitute more than 60% of all currently used antibiotics), infections linked to diseases such 
as pneumonia, tuberculosis, syphilis and gonorrhoea can be treated. However over- and misuse of 
antibiotics has led to the gradual development of resistance and we are now faced with the real threat 
that infections that have been controllable since World War II become dangerous once again. Sadly, 
Alexander Fleming himself predicted such an outcome long ago: ‘the public will demand [the drug 
and]…then will begin an era…of abuses. The microbes are educated to resist penicillin and a host of 
penicillin-fast organisms is bred out which can be passed to other individuals and perhaps from there 
to others until they reach someone who gets a septicaemia or a pneumonia which penicillin cannot 
save. In such a case, the thoughtless person playing with penicillin treatment is morally responsible 
for the death of the man who finally succumbs to infection with the penicillin-resistant organism. I 
hope the evil can be averted’ (53). 
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Antibiotics are, however, not only used in a medicinal context. It is common practice to add 
antibiotics to food supplies for livestock to prevent disease. In 2015 it was reported that up to 80% of 
the antibiotics used in the US were administered to animals via either direct (treatment) or indirect 
(preventative) methods. Of these antibiotics, a significant number of them are clinically relevant for 
the treatment of infections in humans (54).  Administering antibiotics in this fashion to livestock is 
akin to a large scale petri dish where microbes are exposed to low grade antibiotics, which essentially 
encourages bacteria to become resistant. When one considers the scale on which this form of 
experiment is being conducted it is little surprise that resistance is on the rise. Resistant bacteria can 
pass through their hosts (pigs, chickens, cattle) and end up in manure, which then is widely distributed 
as fertiliser. From there resistant bacteria may accumulate in soil, or leeches into waterways, thus 
promoting the distribution of resistance on a large scale. A recent study illustrated the grave 
significance of this cycle; the profiles of over 23,000 bacterial genomes demonstrated how antibiotic 
resistance genes can be transferred from bacteria in food animals to bacteria native to the human 
stomach (55). This cycle affects the entire global resistome and its long-term effect on the environment, 
if not controlled urgently, will be devastating.  
 
The current arms race for supremacy over resistant pathogens does not appear to run in our favour. 
At the very least it appears that the rate of resistance is equal to or higher than the rate of development 
of new and more effective antibiotics. For example, rises in resistance to penicillin led to the 
introduction of carbapenem antibiotics to treat particularly resistant bacteria. However, today an 
increasing number of pathogenic organisms have become resistant to all known forms of clinical 
antibiotics.  Not only is the rise in resistance alarming for health reasons, but the rate at which 
resistance is increasing makes the development of new antibiotics less financially viable for large 
pharmaceutical companies. 10-15 years and millions of dollars in research into novel FDA approved 
antibiotics that quickly become irrelevant is not financially sustainable for any pharmaceutical 
company.  
 
So how large is the problem of antibiotic resistance today? The Center for Disease Control (CDC) 
reports that ‘in America alone at least 2 million become affected with antibiotic resistant bacteria and 
at least 23,000 people die as a direct result of these infections’. The CDC has made efforts to track 
trends in resistance, focusing on emerging and particularly dangerous threats. These include but are 
not limited to Clostridium difficile (CDIFF), which caused 15,000 deaths in the USA in 2015, 
carbapenem-resistant Enterobacteriaceae (CRE) bacteria, NDMs from Klebsiella pneumonia and 
Escherichia coli and, most recently, multi-resistant MCR-1 found in a patients in numerous countries 
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(56-62). Moving forward, efforts are being made by researchers around the globe to find novel strategies 
in an effort to make resistant bacteria sensitive to antibiotics once again. A major target for such 
strategies is a group of enzymes that is very efficient in hydrolysing and thus inactivating β-lactam 
antibiotics, the β-lactamases.  
1.6 β-lactamases and their function  
β–Lactamases catalyze the hydrolysis of the four-membered β-lactam ring, the characteristic feature 
of many commonly used antibiotics such as penicillins, carbapenems, cephalosporins and 
monobactams (Figure. 1.5). These compounds are very effective in impeding the enzymes involved 
in the generation of peptidoglycans in the cell wall of pathogenic bacteria (3,7,63-65). In Gram negative 
bacteria, β-lactam antibiotics invade bacteria via passing through the cell membrane and cell walls. 
Once inside the cell, β- lactams disrupt cell wall biosynthesis by targeting the enzymes responsible 
for peptidoglycan synthesis. β-Lactamases prevent this process by hydrolysing β-lactams before they 
become toxic to the host bacteria (Figure 1.6) (19). 
 
 
Figure 1.5: Classes of β-lactam antibiotics. 
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Figure 1.6: β-lactamase activity within gram negative bacteria. β-lactam antibiotics diffuse across the cell outer membrane 
and cell wall, then neutralise peptidoglycan synthesizing enzymes. β-lactamases render b-lactams inactive through 
hydrolysis (19). 
 
β-Lactamases are divided into four groups based on their mechanism of hydrolysis and cofactor 
requirements (66). Groups A, C and D are serine-β-lactamases (SBLs), which employ a serine residue 
to initiate the hydrolysis of the β-lactam ring (i.e. its opening), whilst group B contains the MBLs, 
which require either one or two metal ions in their active site as essential cofactors for catalysis 
(3,7,65,67,68).  
 
SBLs have been extensively studied and mitigation strategies in the form of co-administered 
inhibitors like clavulanic acid have been proven to be effective in clinical use. Unfortunately, unlike 
for SBLs there are no clinically viable MBL inhibitors available. With increasing trends in resistance 
and declining interest among the major pharmaceutical companies in research into new antibiotics, 
novel MBL inhibitors are urgently needed combat these enzymes directly. To date, the most efficient 
(non-clinical) leads are thiol (69-73), carboxylate (74) or tertazole (75) compounds. Crystal structures for 
MBL-bound thiol based inhibitors such as captopril and thioglycolic acid provide insights into 
inhibitor binding. For both these compounds, crystal structures with the B3 MBLs L1 and SMB 
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support a binding mode in which the sulfur of the inhibitor displaces the bridging hydroxide between 
the two Zn in the active site (70,71,76). This represents a competitive type of inhibition. Unfortunately, 
neither compound is clinically relevant, with captopril being a medication for treating hypertension 
and it is unsafe for patients suffering from ailments such as congestive heart failure, kidney problems 
caused by diabetes, and heart attack recovery (77). It is especially dangerous for pregnant women as it 
can lead to death of the unborn child (78).  
1.7 Metallo β Lactamases  
The first MBLs were discovered by Sabath and Abraham in 1966 in a strain of Bacillus cereus (79). 
This was followed with the discovery of numerous chromosomally encoded MBLs, however, in 1990 
the discovery of MBLs on mobile genetic elements within P. aerguinosa and B. fragillis represented 
the beginning of the increasing trend of resistance we are battling today (80). Wide spread horizontal 
dissemination of resistant genes is a reality as seen by the rapid spread of MBLs such as IMP, VIM 
and NDM globally (81). P. aerguinosa has been identified by both the World Health Organisation and 
the C DC in America as one of the most dangerous pathogens currently in circulation, with in the 
excess of 51,000 infections per year, resulting in over 440 deaths (7,63,82). The primary treatment option 
for this pathogen has been the use of carbapenem antibiotics since the 1980s (83). However, this 
bacterium has evolved the machinery to produce lactam-degrading proteins including the recently 
discovered “Adelaide Imipenemase-1” (AIM-1) in an aboriginal patient in Adelaide, Australia (7,63). 
Structural, mechanistic, spectroscopic and kinetic investigations of AIM-1 are a particular focus of 
this thesis (Chapter 5).  
 
The MBL-encoding genes can reside on either mobile genetic elements that can readily be shared 
between bacteria, or can be chromosomally encoded within the bacterium. Zinc-dependent MBLs 
share minor structural similarities to SBLs and typically have a broad substrate profile, hydrolysing 
almost all known β-lactams. They are further divided into as many as four sub-groups, i.e. B1, B2, 
B3 and B4, depending upon their sequence homology and metal ion requirements for hydrolysis (3,84). 
However, all MBLs do share a characteristic αββα fold as seen in Figure 1.7 (3,7,65).  
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Figure 1.7: The characteristic αββα fold, illustrated using the MBL MIM-2 from S. agarivorans (see Chapter 4 for the 
structural investigation of this enzyme)  
 
The B1 subclass MBLs require two Zn2+ metal ions for catalytic activity (3,65,67,68,85), although at least 
the MBL from B. subtilis (BcII) was shown to be partially active in the mononuclear form (86). This 
subclass of enzymes is currently the most prevalent clinically, and hence, has been the most 
extensively studied. Members include IMP from P. aeruginosa (74,87-89), VIM from K. pneumoniae (90-
95), NDM from K. pneumoniae (58,59,96-102) and BcII from B. cereus (103-107). The binding of substrates 
within this class of MBLs is believed to be affected by two peptide loops within close proximity of 
the metal ions and the extended N-terminus (Figure 1.8), defining the active site pocket (65).  
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Figure 1.8: Representative ribbon structures for MBLs: Class B1 (left – NDM-1, pdb:3ZR9) (108), B2 (middle –CphA, 
pdb:3F9O) (109) and B3 (right – MIM-1; see Chapter 4). Structures are coloured by gradient extending from the C terminus 
(red) to the N terminus (blue). 
 
In contrast, B2-type MBLs require only one metal ion in their active site for optimal catalytic activity; 
the binding of a second metal ion leads to the inactivation of the enzyme (3,110). Homologous families 
within the B2 subclass include CphA from A. hydrophilia (109,111-117) and SfH from S. fonticola (118,119). 
Unlike B1 MBLs, B2 enzymes have an extended α-helix in the loop 2 position that defines the active 
site pocket, making them particularly narrow in geometry (Figure 1.8). Consequently, these MBLs 
are more selective for their preferred substrates, displaying specific activity towards monobactams, a 
group of substrates that is poorly inactivated by other MBLs (3,110,111,114). 
 
B3-type MBLs are similar to B1 enzymes in requiring two metal ions in their catalytic site to be fully 
active; however, their active site architecture is quite different as can be seen in Figure 1.8 (7). Both 
loop 1 and 2 regions differ considerably from those seen in B1 and B2 MBLs, and especially in the 
case of MIM-1, it is proposed that an arginine residue (Arg46) located in the N-terminus may have 
an active role in substrate recognition, which is elaborated on further in Chapter 4. Currently, there 
are over 151 proteins within the B3 subclass, with more than 39 associated crystallographic structures; 
however, this number is steadily rising(120). Examples of enzymes form this subclass include: L1 from 
S. maltophilia (76,121-128), SMB from S. marcescens (70,71), BJP from B. japonicum (129,130), FEZ from 
F. gormanii (131-134), LRA and Rm3 from functional metagenomic studies (135,136), AIM from P. 
aeroginosa (7,72,137), MIM-1 from N. pentaromativorans and MIM-2 from S. agarivorans (26); LRA, 
AIM and the two MIMs will be discussed in more detail in subsequent chapters (i.e. Chapters 4, 5 
and 6).  
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One MBL, expressed by S. proteamaculans (SPR-1), may belong to the proposed B4 subgroup. The 
metal ion requirement of SPR-1 is different from the other MBLs; in its resting state the enzyme 
appears to bind only one Zn2+, however, upon interaction with a substrate, a bimetallic centre is 
formed that is catalytically active (138). The substrate-initiated binding of a catalytically important 
metal has been seen before for the phosphatase GpdQ from E aerogenes (3,23,51,122,139-145).   
 
 
 
Figure 1.9: MBL active sites – B1 (top left), B2 (top right) and B3 (bottom centre) 
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Table 1.1: Zn coordination and associated geometries of MBLs from the different subgroups 
Subclass Zn1 Ligands Zn1 
Geometry 
Zn2 Ligands Zn2 Geometry 
B1 His116, His118, His196 
& µW1 
Tetrahedral Asp120, Cys221, 
His263, µW1 & W2 
Trigonal 
bipyramidal 
B2 Not occupied in active 
form of the enzyme 
- Asp120, Cys221, 
His263  
Tetrahedral 
B3 His116, His118, His196 
& µW1 
Tetrahedral Asp120, His121, 
His263, µW1 & W2 
Trigonal 
bipyramidal 
B4 His116, Arg118, His196 
µW1 (upon Zn2 
binding) 
Tetrahedral Asp120, 
Gln121⁄Ser221, Ala262 
µW1 (upon Zn2 
binding) 
Trigonal 
bipyramidal 
 
 
    
Figure 1.9 and Table 1.1 illustrate the relevant Zn-ligand interactions seen for MBLs from different 
subgroups. Whilst B1- and B2-type MBLs have identical ligands for the Zn2 binding site, they differ 
in the Zn1 metal centre. In contrast, in B3 MBLs Cys221 in Site 2 is replaced by a histidine (His121), 
but their Site is identical to that of B1 MBLs. In both B1 and B3 MBLs Zn1 and Zn2 are bridged by 
a water molecule (µ-H2O; the likely nucleophile that initiates the hydrolysis) 
(7,65,95,122,146,147).  In 
contrast, B4 MBLs both metal binding sites differ from other MBLs. 
 
Proposed mechanisms for both mononuclear (i.e. B2 subgroup) and binuclear (i.e. B1, B3 and B4 
subgroups) MBLs have been published, with a common theme involving a nucleophilic hydroxide 
group that is either terminally bound (B2 MBLs) or bridging both metals (B1, B3 and B4 MBLs) 
(15,19,65,105,124,139,148-153). Figure 1.10 illustrates simplified mechanistic schemes for both models using 
a truncated penicillin molecule as the substrate.  
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Figure 1.10: Proposed reaction mechanisms for mononuclear (top) and binuclear MBLs (bottom) (19). 
1.8 Scope of this thesis 
As illustrated in the preceding sections BMHs constitute a diverse group of enzymes, relevant to both 
medicinal applications as drug targets (e.g. MBLs, PAPs, CpsB) or biotechnology applications in 
form of catalysts that can break down and thus detoxify dangerous compounds in the environment 
(e.g. OpdA, GpdQ). In this thesis I employed a series of physico-chemical methods on these 
structurally and functionally distantly related enzymes to gain a better understanding into the factors 
that allow these biocatalysts to be highly efficient for their respective reactions. I envision that these 
insights can be translated either into successful strategies to develop clinically useful inhibitors, or 
modify some of these enzymes to be more suited for direct application in the environment. 
Specifically, the kinetic, spectroscopic, structural and crystallographic properties of PAP, OpdA, 
CpsB, AIM-1, MIM-1 and MIM-2 enzymes are explored with a view to provide insights into the 
mechanism of hydrolysis employed by these enzymes.  
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1.9 The aims of the project 
The aims of this project include: 
 Visualisation of the reaction trajectory and transition state in a hydrolytic reaction catalysed 
by the BMH PAP (Chapter 2).  
 High resolution crystal structure of a fluoride-inhibited OP-degrading metallohydrolase 
(Chapter 3).  
 Crystal structures of the B3 MBLs MIM-1 and MIM-2 from environmental microorganisms 
(Chapter 4). 
 AIM-1: an antibiotic-degrading BMH that displays mechanistic flexibility (Chapter 5) 
 Spectroscopic investigations of the structure and mechanism of the BMHs MIM-1, MIM-2, 
LRA-8 and CpsB (Chapter 6). 
 General conclusions and future directions (Chapter 7). 
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Figure 2.1 : Reaction trajectory in a metal ion-dependent hydrolase: A high resolution structure of a purple acid 
phosphatase (PAP) shows two binding modes for a substrate mimic.  Their overlay provides unprecedented insight into 
the structure of the transition state of the reaction catalysed by this enzyme. 
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2.2 Abstract 
Metallohydrolases are a vast family of enzymes that play crucial roles in numerous metabolic 
pathways. Several members have emerged as targets for chemotherapeutics.  Knowledge about their 
reaction mechanisms and associated transition states greatly aids the design of potent and highly 
specific drug leads. Using a high-resolution crystal structure, we have probed the trajectory of the 
reaction catalysed by purple acid phosphatase, an enzyme essential for the integrity of bone structure. 
In particular the transition state is visualized, thus providing detailed structural information that may 
be exploited in the design of specific inhibitors for the development of novel anti-osteoporotic 
chemotherapeutics. 
2.3 Keywords:  
Metallohydrolase, phosphomonoester, phosphatase, transition state, metalloenzyme 
2.4 Introduction: 
Metal ion-dependent hydrolases (metallohydrolases) are a large family of enzymes that play a central 
role in numerous biological functions, including energy metabolism, signal transduction, biosynthesis 
and bone turnover (1,154,155). An increasing number of these enzymes have become targets for the 
development of chemotherapeutics against a wide range of diseases. An example is the metallo-β-
lactamases (MBLs), a family of Zn2+-dependent enzymes that break down the most commonly used 
antibiotics, and are a major contributor to the emergence of antibiotic-resistant pathogens (150,156-158). 
The development of promising drug leads that target a specific member within the metallohydrolase 
family is challenging because the catalytically relevant metal ion centre is often close to the surface 
of the protein, thus increasing the risk of low binding specificity. The design and synthesis of leads 
with high specificity for a particular target is, however, strongly aided by detailed information for the 
reaction mechanism and transition state(s) of this reaction.(159,160) 
 
Here, we solved the high-resolution crystal structure (1.18 Å) of the metallohydrolase purple acid 
phosphatase (PAP) (161) from porcine uterus, and combined with previously reported structures of that 
enzyme individual steps for the transformation of a substrate to a product are tracked. In particular, 
this structure facilitates insight into the transition state of the reaction. PAP is able to hydrolyze a 
broad range of phosphomonoester substrates and plays a crucial role in bone metabolism; high levels 
of PAP in blood serum is a diagnostic marker for osteoporosis (162). The identity of the preferred in 
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vivo substrate(s) of PAP is still unclear, but both ATP and ADP (but not AMP) are hydrolyzed 
effectively by this enzyme (163). PAP is the only known metallohydrolase that requires a heterovalent 
dinuclear metal center of the form Fe3+-M2+ (where M = Fe, Zn or Mn) in order to be catalytically 
active.(164) A distinctive characteristic feature of PAP is its purple color in concentrated solutions, 
which is due to a charge transfer transition between the Fe3+ and a tyrosine ligand in the active site 
(Figure 2.2) (161). Importantly, the amino acid side chains that coordinate the metal ions are invariant 
in all PAPs and highly conserved among numerous members of the metallohydrolase family (1,154,161). 
 
Despite the availability of detailed structural (8,165-169), kinetic (21,170-174) and spectroscopic (175-178) data, 
several aspects of the catalytic mechanism employed by PAPs remain obscure, including the mode(s) 
of substrate binding, the identity of the reaction-initiating nucleophile(s) and the nature of the 
transition state. The observation that PAP is also able to hydrolyze both ester bonds in some diester 
substrates in a processive (as opposed to sequential) manner demonstrates that the active site is 
capable of accommodating diverse substrates and that at least two different nucleophiles can be active 
(21). Furthermore, metal ion replacement studies indicated that these nucleophiles do not necessarily 
need to be bound to one of the metal ions (174). In the proposed transition state the phosphate group 
adopts the geometry of a five-coordinate trigonal bipyramidal oxyphosphorane, but its structure is yet 
to be visualized (167). 
 
Our focus was on the elucidation of the likely transition state of the reaction catalysed by the di-iron 
pig PAP, using inorganic phosphate (Pi) as a probe. Pi is not only the smallest substrate mimic for 
PAP, but also the final product of the reaction as well as a mild competitive inhibitor of catalysis, 
with inhibition constants that are conserved across all known PAPs; reported Ki values are in the high 
micro- to low millimolar range (167,170-173). This similarity in Ki values indicates that the binding mode 
of Pi is similar in different PAPs. Furthermore, rapid kinetics measurements demonstrate that the 
initial association between Pi and various PAPs is conserved (173,174), suggesting that this tetraoxo 
anion is a suitable agent to monitor the transformation of a substrate molecule to product. 
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Figure 2.2: Structure of pig PAP at 1.18 Å. (A) Connolly surface showing the monomeric structure of the enzyme. Orange 
spheres indicate the presence of the metal ions in the active site. (B) Active site showing the electron density for the two 
metal ions, the μ-OH 
2.5 Results 
PAP was purified from the uterus of a pregnant sow using a previously published protocol (165). The 
enzyme (66 mg/mL) was crystallized at 20°C using the hanging-drop vapor-diffusion method with 
crystallization conditions identical to those described previously. Specifically, at 5.0 the pH was close 
to the condition optimal for the catalytic activity of PAPs (165). Crystallographic data were collected 
by remote access on beamline MX-2 at the Australian Synchrotron (Melbourne) using BLU-ICE (179). 
 
The data were integrated, scaled and merged using HKL-2000 (180). Refinement and model building 
were carried out using PHENIX 1.8.4 (181) and COOT 0.7 (182) respectively, using the previously 
published coordinates for pig PAP with PDB code 1UTE (165,183). All atoms were subsequently refined 
with anisotropic B-factors; most hydrogen atoms were fitted as riding models, though the proton of 
the bridging hydroxide was added manually based on the electron density. Relevant crystallographic 
data and refinement statistics are summarized in Table 2.1. There is a single monomer of pig PAP in 
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the asymmetric unit with density for the presence of two Fe ions in the active site (Figure 2.2 A-B). 
Also well-defined within the active site is a bridging group we ascribe to a hydroxide ion and Pi in 
two alternative binding modes (discussed below) (Figure 2.2 C-D). 
 
Table 2.1: Data collection and refinement statistics for PAP from porcine uterus. 
Diffraction data  
    Resolution Range (Å) 75.05 - 1.18 
    Observations (I>(I)) 390,157 (45,794) 
    Unique reflections (I>(I)) 98,587 (13,107) 
    Completeness (%) 91.3 (83.9) 
    Mean <I/(I)> 11.2 (1.7) 
    Rmerge 0.068 (0.859) 
    Rpimb 0.037 (0.503) 
    Multiplicity 4.0 (3.5) 
Crystal parameters  
    Space group P212121 
    Unit cell lengths (Å) a = 63.12 b = 69.98 c = 75.05 
    Unit cell angles (°) α = 90.0 β = 90.0 γ = 90.0 
Refinement  
    Rworkc 0.1414 
    Rfreec  0.1555 
    rmsd bond lengths (Å) 0.007 
    rmsd bond angles (o) 0.980 
Ramachandran plot statistics  
    Favoured regions 97.4 
    Outlier regions 0.00 
PDB code 5UQ6 
 
 
aValues in parentheses are for the outer resolution shell (1.25-1.18 Å). bRpim,;  cRwork = Σ||Fobs|-
|Fcalc||/Σ|Fobs|, Rwork is calculated based on the reflections used in the refinement (95% of the total 
data) and Rfree is calculated using the remaining 5% of the data.  
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The overall structure of pig PAP (Figure 2.3 A) is virtually identical to that described in a previous 
study of that enzyme (165). The significance of the present structure is that it provides high-resolution 
insight into the active site and mechanistic features of PAP and related enzymes. Specifically, the 
metal ion-bridging oxygen appears to be protonated, as evidenced by residual difference density after 
the fitting of the oxygen atom (Figure 2.3 A-C). In support of this assignment is that this hydrogen 
atom is within H-bond distance of the phosphate oxygen atoms O1 and O4 (Figure 2.3). While this 
H-bond between the μ-OH group and Pi supports a role of this bridging ligand in substrate and/or 
product binding, and possibly also the stabilization of the transition state, it argues against the 
proposed role of this ligand as the hydrolysis-initiating nucleophile, at least under the conditions 
employed to crystallize pig PAP. 
 
 
Figure 2.3: Phosphate coordination in the active site of pig PAP. In (A) both modes are shown, while in (B) and (C) the 
modes are deconvoluted. (D) Illustrates the geometry of the five-coordinate trigonal bipyramidal oxyphosphorane 
transition state that results from the overlay of the two Pi binding modes. The bridging hydroxide plays a pivotal role in 
both substrate and product binding. 
 
Of particular mechanistic importance is the observation of alternative binding modes of Pi in the 
active site (Figure 2.2 C and D).  In one mode of Pi binding (Figure 2.2 D; comprising ~40% of the 
population) the substrate mimics only coordination to the redox-active, non-chromophoric metal ion. 
However, hydrogen bonding between O1 of the bound phosphate moiety and the metal ion-bridging 
hydroxide leads to a stabilization of the complex. This complex is likely to illustrate the substrate-
bound state immediately preceding hydrolysis. Importantly, in this binding mode the phosphorous 
atom of the substrate mimic is directly in line for a nucleophilic attack by a hydroxide bound to the 
chromophoric Fe3+. In the other binding mode (Figure 2.2 C; comprising ~60% of the population) Pi 
forms a μ-1,3 complex with the bimetallic metal center; in addition to these two coordination bonds 
μ-OH forms bifurcated H bonds with O1 and O4. This complex is likely to represent the product-
bound state immediately after hydrolysis. In fact, the superposition of the two Pi binding modes 
(Figure 2.3 D) leads to a trigonal bipyramid that mimics the proposed transition state of the reaction 
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(167). In this state oxygen atoms O1, O2 and O3 span the plane of the pyramid, while O4 represents 
the position of the nucleophile that initiated the reaction and O5 that of the leaving group. 
 
Here, it is salient to point out that NMR and X-ray absorption studies indicated that at least in the 
resting form of PAP the Fe3+ centre may be five-coordinate and no terminally bound hydroxide ligand 
is present (176,177). Furthermore, rapid kinetics measurements in combination with metal ion 
replacements have demonstrated that there is more than one active nucleophile in the active site; 
experimental conditions such as pH and the identity of the substrate determine which nucleophile(s) 
will be selected for a particular reaction (21,171,174). Hence, while not observed experimentally, it is 
plausible that a nucleophilic hydroxide enters the coordination sphere of the chromophoric Fe3+ upon 
substrate binding. In agreement with this observation a series of studies with PAP biomimetics 
supports a role for such a terminal ligand as the effective nucleophile for the hydrolytic reaction (184-
186). 
 
 
 
Figure 2.4: Proposed reaction mechanism employed by the FeFe pig PAP. Note that focus here is on the first coordination 
sphere only. Two Histidine residues in the second sphere also play important roles in substrate binding and transition state 
stabilization but are not shown for illustrative purposes (4).  
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The structure of pig PAP with two coordination modes of Pi completes the comprehensive 
visualization of the trajectory of the reaction coordinate from the initial substrate association to the 
product-bound state (Figure 2.4).  In Step 1 the substrate binds in a catalytically non-competent 
manner whereby it interacts, via hydrogen bonds, with the μ-OH group in the active site.  This mode 
of binding was initially proposed based on stopped-flow kinetics measurements (173) and was later 
observed in PAP from red kidney bean in complex with the tetraoxo anion sulfate (169). In Step 2, 
illustrated by the monodentate mode of phosphate binding (Figure 2.2 D), the substrate rearranges to 
form a catalytically competent Michaelis complex. Possibly, at this stage a water molecule enters the 
active site and coordinates to the chromophoric ferric centre.  The substrate is now primed for an 
attack by this Fe3+-bound nucleophile. The attack (Step 3) leads to a five-coordinate trigonal 
bipyramidal oxyphosphorane that defines the transition state of the reaction. Figure 2.3 D illustrates 
the structure of this state; oxygen atoms O1-O3 span the plane of the pyramid, while O4 represents 
the incoming nucleophile. The hydrogen bond between O2 and the μ-OH plays a pivotal role in 
stabilizing this state. Release of the leaving group from O5 (Step 4) then leads to a product-bound 
complex, illustrated in Figure 2.2 C.  The subsequent release of the phosphate moiety then regenerates 
the active site for the next catalytic cycle. 
2.6 Conclusion 
In summary, the elucidation of the crystal structure of pig PAP at high resolution, together with the 
presence of a substrate mimic in two distinct binding modes has facilitated detailed insight into the 
transition state of the reaction catalysed by a bimetallic hydrolase (previous attempts to crystallize a 
PAP in presence of transition state mimics such as vanadate or aluminium fluoride failed, either 
because no suitable crystals for diffraction studies were obtained, or the resolution was too low for a 
conclusive data interpretation). Of particular relevance is the hydrogen bond formed between one of 
the oxygen atoms of the phosphate group of the substrate and the metal ion-bridging hydroxide, a 
feature that may be common amongst metallohydrolases. It is thus likely that the observed transition 
state is relevant to enzymes other than PAPs, an interpretation that may be exploited in the 
development of future transition state mimics/chemotherapeutics against a wide range of disorders. 
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Figure 3.1: Crystal structure of the fluoride-inhibited organophosphate-degrading metallohydrolase from Agrobacterium 
radiobacter (OpdA). Fluoride displaces the metal ion-bridging nucleophile and disrupts the hydrogen bond network 
linking the metal ion center to the substrate binding pocket.  
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3.1 Abstract: 
Metal ion-dependent, organophosphate-degrading enzymes (OP hydrolases) have received increasing 
attention due to their ability to degrade and thus detoxify commonly used pesticides and nerve agents 
such as sarin and VX. These enzymes thus garner strong potential as bioremediators. The OP 
hydrolase from Agrobacterium radiobacter (OpdA) is one of the most efficient members of this group 
of enzymes. Previous studies have indicated that the choice of the hydrolysis-initiating nucleophile 
may depend on the pH of the reaction, with a metal ion-bridging hydroxide being preferred at low 
pH, and a terminally coordinated hydroxide at high pH. Furthermore, fluoride was shown to be a 
potent inhibitor of the reaction, but only at low pH. Here, the crystal structure (1.3 Å, pH 6) of OpdA 
in presence of fluoride is described. While the first coordination sphere in the active site displays 
minimal changes in the presence of fluoride, the hydrogen bonding network that connects the 
dimetallic metal center to the substrate binding pocket is disrupted. Thus, the structure of fluoride-
inhibited OpdA demonstrates the significance of this hydrogen bond network in controlling the 
mechanism and function of this enzyme. 
3.2 Keywords:  
Binuclear metallohydrolases, organophosphate-degrading enzymes, fluoride inhibition, 
bioremediation 
3.3 Introduction: 
Organophosphates (OPs) are non-natural compounds that have been synthesized since the late 1800s 
and have been used as petroleum additives, plasticizers and, in particular since World War II, as 
pesticides (187). Since then OPs have played a crucial role in facilitating the global expansion of 
agriculture, but due to their inherent toxicity they pose a considerable risk to both human and 
environmental health (5). While currently no clean and effective ways for their decontamination are 
available, microorganisms exposed to such compounds have evolved the enzymatic machinery to 
utilize them as nutrients to obtain phosphorous for metabolic functions (5). Of particular relevance are 
OP-degrading phosphotriesterases (PTEs), the first of which was isolated in 1973 from a strain of 
Flavobacterium (188). PTEs have since been identified in several microorganisms, including 
Pseudomonas diminuta (40) and Agrobacterium radiobacter (189). The PTE expressed by P. diminuta 
(i.e. OPH) is identical to that found in the Flavobacterium, whereas the A. radiobacter enzyme (i.e. 
OpdA) shares approximately 90% sequence with the other PTEs.  
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OPH and OpdA are among the best-characterized PTEs to date. Both contain a di-metallic metal 
center in their active sites with invariant amino acid ligands (Figure. 3.2). These include H55, H57 
and D301 for the metal ion in the more buried α site, and H201 and H230 for the more solvent-
exposed metal ion in the β site (unless stated otherwise residue numbers refer to the sequence of 
OpdA). In both enzymes the metal ions are bridged via a carboxylated lysine residue (K169) and a 
water/hydroxide molecule (190). The precise metal ion composition for the two enzymes is not firmly 
established; while an analysis of anomalous scattering data indicated that native OpdA may have a 
preference for the heterodinuclear Fe2+-Zn2+ combination (191), both enzymes can readily be activated 
with a range of divalent metal ions including Zn2+, Co2+, Mn2+ and Cd2+  (22,192).  
 
Proposed models for the reaction mechanisms employed by the two enzymes are also similar, 
invoking a role for the metal ion-bridging hydroxide as nucleophile initiating hydrolysis of the OP 
triester (187). However, significant variations are observed with respect to their catalytic efficiency, 
substrate selectivity and metal ion affinities (5,193,194). Site-directed mutagenesis and in vitro evolution 
studies demonstrated that in particular two residues in the substrate binding pocket may play an 
important role in mediating these variations: while R254 and Y257 in OpdA are integrated into an 
extensive hydrogen bonding network that connects the substrate binding pocket to the metal ion 
center (Figure. 3.2 A), the corresponding residues in OPH are two histidines, and no hydrogen bond 
network is present (Figure 3.2 B). In OpdA this network controls the conformation of R254: when 
present the side chain is kinked, allowing access to the metal center, when absent the side chain is 
more linear, obstructing access (195). It is this sequestration of the catalytic site that may underlie (i) 
the preference of OpdA for smaller substrates, (ii) this enzyme’s enhanced catalytic efficiency and 
(iii) its increased metal ion affinity when compared to OPH (195). This interpretation may also account 
for the distinct variation observed between OpdA and OPH with respect to their interaction with 
fluoride. Fluoride is a potent inhibitor for a number of metal ion-dependent hydrolases, including the 
di-Ni2+ urease (196), the di-Mn2+ arginase (197,198) and the Fe3+ -M2+ purple acid phosphatase (PAP, 
where M = Fe, Zn or Mn) (199,200). OpdA is also inhibited by fluoride (Ki ~ 300 nM at pH 6.5), and 
the uncompetitive mode of inhibition, together with a strong exchange coupling of the metal ions is 
consistent with fluoride displacing the hydrolysis-initiating μ-OH (195). Considering that OPH is 
expected to employ a mechanism similar to that of OpdA (vide supra) it is surprising that this enzyme 
is not inhibited by fluoride (195). 
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Figure 3.2: Structures of OpdA and OPH. (A) Active site of OpdA in its resting state, illustrating the extensive hydrogen 
bond network connecting the metal ion center to the substrate binding pocket. (B) Active site of OPH; no hydrogen bond 
is present. (C) Active site of OpdA in presence of fluoride. The hydrogen bond network is disrupted and the substrate 
binding pocket residues R254 and Y257 display conformational flexibility 
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3.4 Results: 
In order to better understand the interaction between OpdA and fluoride the enzyme was crystallized 
in presence of this inhibitor. Recombinant di-Co2+ OpdA was expressed and purified using a well-
established procedure (22,195,201,202). The isolated enzyme was >95% pure, judged by SDS PAGE 
analysis, and concentrated to 20 mg/mL for crystallization in presence of 100 μM fluoride (NaF). The 
enzyme was crystallized at 20 °C using the hanging-drop vapor-diffusion method. The crystallization 
solution was made up in 10 mM MES, pH 6.0, with 0.16 M calcium acetate, 80 mM sodium carbonate 
and 14% v/v PEG 1000. Crystals formed after five days.  
Table 3.1: Data collection and refinement statistics for di-Co2+ OpdA in the presence of fluoride 
Diffraction data  
    Resolution Range (Å) 47.2 - 1.3 
    Observations (I>(I))a 11143063 (48587) 
    Unique reflections 
 (I>(I)) 
105162 (4986) 
    Completeness (%) 99.7 (96.6) 
    Mean <I/(I)> 15.2 (2.3) 
    Rmerge 0.073 (0.842) 
    Rpim 0.023 (0.279) 
    Multiplicity 10.9 (9.7) 
Crystal parameters  
    Space group P 31 2 1 
    Unit cell lengths (Å) a = 109.072 b = 109.072            
c = 62.79 
    Unit cell angles (°) α = 90 β = 90 γ = 120 
Refinement  
    Rwork
b 0.1308 
    Rfree
b  0.1437 
    rmsd bond lengths (Å) 0.007 
    rmsd bond angles (o) 1.05 
Ramachandran plot 
statistics 
 
    Favored regions 97.21 
    Outlier regions 0.00 
PDB code 5VEJ 
 
aValues in parentheses are for the outer resolution shell (1.6-1.3 Å). bRwork = Σ||Fobs|-
|Fcalc||/Σ|Fobs|, Rwork is calculated based on the reflections used in the refinement (95% of the total 
data) and Rfree is calculated using the remaining 5% of the data. 
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X-ray diffraction data were collected by remote access on beamline MX-2 at the Australian 
Synchrotron (Melbourne) using BLU-ICE (179). The data were integrated, scaled and merged using 
HKL-2000 (180). Refinement and model building were carried out using PHENIX 1.8.4 (181) and COOT 
0.7 (182), respectively, with the previously published coordinates for OpdA with PDB code 2D2J (165). 
All atoms were subsequently refined with anisotropic B-factors. The relevant crystallographic data 
are summarized in Table 3.1, and coordinates for the structure have been deposited in the Protein 
Data Bank with accession code 5VEJ.  
 
 
Figure 3.3: Active site of OpdA in presence of fluoride. R254 and Y257 adopt two distinct conformations, a less abundant 
one that resembles the conformation observed in the absence of fluoride (~20%) and a more abundant one (~80%) that 
leads to a sequestration of the active site associated with the rearrangement of R254. In both conformations the hydrogen 
bond network that connects the substrate binding pocket to the metal ion center is disrupted. 
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3.5 Discussion:  
The overall structure of OpdA is virtually indistinguishable from previously reported structures of 
that enzyme (6,193,202). The subunit structure adopts a TIM barrel fold, characteristic for members of 
the amidohydrolase superfamily (203). Crystallizing OpdA in presence of its uncompetitive inhibitor 
fluoride also has only a marginal effect on the first coordination sphere of the active site; the metal-
metal distance changes from 3.60 Å to 3.67 Å when structures of fluoride-free (2D2J) and fluoride-
bound complexes are compared. Similarly, the distances between the metal ions in the α and β sites 
to the bridging ligand are only minimally affected by the addition of fluoride, changing from 1.94 Å 
to 1.96 Å for the distance between the metal ion in the α site and the ligand, and from 2.09 Å to 2.14 
Å for the corresponding bond involving the metal ion in the β site. More significant is the effect of 
fluoride on the outer coordination sphere (Figures 3.2 C and 3.3). In particular the conformations of 
residues R254 and Y257 are affected. In the OpdA structure obtained in the absence of fluoride 
(Figure 3.2 A) the two side chains appear to be rigid and integrated into an extensive hydrogen 
bonding network that connects these two residues to D301, a ligand of the metal in the α site 
(discussed above). In the presence of fluoride structural flexibility is observed, whereby two distinct 
conformations of both R254 and Y257 are observed (Figure 3.3). One of these (~20% occupancy) 
resembles that observed in the fluoride-free structure, but the hydrogen bond network is disrupted 
(compare Figures 3.2 A and 3.2 C). In the other conformation (~80% occupancy) Y257 is tilted away 
from its original position and R254 moves towards the metal in the β site, obstructing access to the 
catalytic center. 
 
The crystal structure of OpdA in the presence of fluoride thus provides insight into the mechanism of 
how this anion may inhibit this enzyme. The crystallographic data do not allow an unambiguous 
identification of the metal ion-bridging ligand, but due to the uncompetitive nature of fluoride 
inhibition, together with a significant change to the metal-metal interaction recorded by magnetic 
circular dichroism (12) it is plausible that fluoride displaces μ-OH. The resulting effect of this 
replacement on the first coordination sphere is subtle, but sufficient to affect the hydrogen bonding 
network that connects ligand D301 to Y257 (Figure 3.2). The net effect of this disruption is that R254 
is moving closer to the metal ion center, rendering access to the active site for the substrate more 
difficult and thus inhibiting the overall reaction. 
 
It is important to point out that the inhibitory effect of fluoride for OpdA is abolished at high pH (>9), 
an observation that was interpreted in terms of having available a hydroxide that is terminally bound 
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to one of the two metal ions and acts as nucleophile under high pH conditions (12). According to the 
crystal structure of OpdA in presence of fluoride (Figure 3.3) the terminal ligand bound to the metal 
ion in the α site is a suitable candidate for this nucleophile. In the absence of a crystal structure of 
OPH obtained in presence of fluoride the reason for this enzyme’s lack of inhibition by this anion 
remains obscure. However, considering that this enzyme has a lower affinity for the metal in the β 
site than OpdA, despite identical amino acid ligands (10), indicates some variation in the coordination 
environment of these two enzymes, possibly linked to a difference in water molecules present in the 
enzyme-substrate complex. Insofar, in OPH substrate binding may alter the metal ion site in a way 
that prevents fluoride from binding, or of it binds, it may not displace the relevant nucleophile that 
initiates catalysis. Additional studies are required to fully understand the factors that contribute to the 
considerable functional variations observed for two highly homologous enzymes such as OpdA and 
OPH. However, the present study clearly demonstrated the significance of a hydrogen bonding 
network in the mechanism employed OpdA. For OPH, that lacks this network, the mechanism may 
be more reliant on a flexibility in the immediate coordination environment, especially of the metal 
ion in the β site. The study thus demonstrates how relatively subtle changes in a protein sequence can 
have significant effects with respect to enzymatic properties. This observation makes PTEs such as 
OpdA and OPH ideal candidates for optimization into catalyst that can be employed in 
bioremediation. Efforts towards this goal are in progress. 
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Chapter 4 
Crystal structures of the B3 MBLs MIM-1 and MIM-2 from 
environmental microorganisms 
 
4.1 Abstract 
Genes that confer antibiotic resistance can rapidly be disseminated from one microorganism to 
another by mobile genetic elements, thus transferring resistance to previously susceptible bacterial 
strains. In particular the misuse of antibiotics in health care and agriculture has provided the ideal 
evolutionary pressure that has led to a rapid recent spread of β-lactamases, i.e. SBLs and MBLs, 
enzymes that are highly potent in inactivating most of the commonly used β-lactam antibiotics (see 
also Chapter 1). However, genes that confer antibiotic resistance are not only associated with 
pathogenic microorganisms, but are also found in non-pathogenic (i.e. environmental) 
microorganisms. Two such examples are the MBLs from Novosphingobium pentaromativorans and 
Simiduia agarivorans, i.e. Maynooth IMipenemase 1 (MIM-1) and 2 (MIM-2), respectively. Previous 
studies demonstrated that these proteins are homologous to B3-type MBLs, with catalytic properties 
similar to well-characterised MBLs such as AIM-1 (see Chapter 5). Here, the crystal structures of 
MIM-1 (2.60 Å) and MIM-2 (1.84 Å) are discussed and compared to MBLs from pathogenic origins.  
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4.2 Introduction 
United States, Nevada, September 2016, a woman in her seventies died from an infection caused by 
carbapenem-resistant Enterobacteriaceae bacteria, resistant to all available antibiotics(204). This 
woman was not the first to die of antibiotic-resistant bacteria. In fact, in 2013 the Centre for Disease 
and Control and Prevention (CDC) of the United States published a report where it is estimated that 
at least 2 million people acquire serious infections every year and at least 23,000 people die from the 
direct result of antibiotic resistant infections (82). It was estimated that in 2011 alone there were 
310,000 cases of multidrug-resistant tuberculosis, the majority of them occurring in China, India, 
Pakistan, Russia and South Africa (205,206). Nonetheless, the problem is global and bound to worsen if 
no action is taken.   
 
While antibiotic resistance has emerged amongst both Gram-positive and Gram-negative pathogens, 
it is the latter group (in particular the ESKAPE pathogens, i.e. Enterococcus faecium, Staphylococcus 
aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and the 
Enterobacter species) that poses a particularly alarming problem as there are only a few antimicrobial 
agents available to battle these pathogens (205,207). The misuse of antibiotics is the single most 
important factor leading to antibiotic resistance around the world. A successful strategy used by the 
pathogens to acquire resistance is through the production of enzyme MBL, a member of the BMH 
family (208) (see also Chapter 1). Sustained periods of haphazard use of antibiotics in both the 
medical sector and agriculture, combined with enhanced global motility, have attributed to the 
growing threat of antibiotic resistance (209). Although the main contributor to their recent sharp rise 
is ascribed to anthropogenic activities (210,211), antibiotic-resistant bacteria have also been detected in 
pristine, unchallenged environments such as LRA-8 (this particular enzyme is further investigated in 
Chapter 6) (26,136). Therefore, the study of the properties of MBLs from “unusual”, i.e. pristine 
environments may hold clues about the origin and evolution of a major strategy employed to confer 
antibiotic resistance. It may also assist in the development of new drugs to combat this major threat 
to modern health care.  
 
In the search for novel MBL-like proteins from unusual organisms, our group previously identified 
two possible candidates, one from Novosphingobium pentaromativorans and one from Simiduia 
agarivorans, both marine microorganisms. The proteins were labelled Maynooth IMipenemase 1 
(MIM-1) and 2 (MIM-2), respectively (25,26,212). Their nomenclature was associated with the place 
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(Maynooth University, Ireland) where they were initially discovered, but as will be demonstrated in 
this Chapter, these labels are not ideal as they infer a close similarity of these two proteins. Although 
both MIM-1 and MIM-2  are homologous to members of the B3 subgroup of MBLs they share only 
23% protein sequence similarity with each other (26). Furthermore, the true biological function of these 
enzymes is not yet known as they are multifunctional in vitro, possessing both MBL and N-
acylhomoserine lactonase activities (26). In order to further probe the function of MIM-1 and MIM-2, 
their crystal structures were solved here and compared with those of other MBLs. 
4.3 Materials and Methods 
MIM-1 and MIM-2 were expressed and purified using a previously published procedure (137). In brief, 
BL21 (DE3) cells were transformed with the plasmid blaMIM-1 or blaMIM-2 pJ411 (vector commercially 
available from DNA 2.0).  The proteins were expressed in LB medium, supplemented with 50 µg/ml 
kanamycin. Initially, the cell cultures were grown at 37 °C until the OD600 reached 0.4 - 0.6. Then 
expression was induced by addition of 1 mM of IPTG at 18 °C; subsequently, the cell culture was 
grown for another 48 hours. Cells were then harvested by centrifugation and purified on a Hi-trap Q 
FF column, equilibrated with 20 mM Hepes buffer, pH 7.5, 0.15 mM ZnCl2. Then proteins were 
eluted with a linear gradient from 0 to 1 M NaCl. Fractions containing activity against cefuroxime 
were combined, concentrated and subsequently loaded onto a Hiprep 16-60 sephacryl S-300 HR gel 
filtration column and eluted with 50 mM Tris buffer, pH 7.2, containing 0.15 mM ZnCl2.  The 
fractions were at least 95% pure, as judged by SDS-PAGE gel analysis, and the purified protein was 
stored in 10% glycerol at -20 °C.  The protein concentration was determined by measuring the 
absorption at 280 nm (ε = 36,815 M-1cm-1 and 41,285 M-1cm-1 per monomer for MIM-1 and MIM-2, 
respectively)(26).  
4.4 Crystallisation, X-ray diffraction data collection and refinement 
Crystals were prepared using the hanging-drop diffusion method at 20 C.  The drop solution 
contained 300 µL of the desired enzyme (i.e. MIM-1 or MIM-2) at approximately 40 mg/mL and 300 
µL of the precipitant buffer. The precipitant buffer used for MIM-1 was 0.05 M citrate, pH 5, 0.05 M 
Bis Tris Propane, pH 9.7, and 16% w/v PEG-3350; for MIM-2 it was 0.1 mM DS56E8 (a detergent), 
0.1 M sodium citrate, pH 5.5, and 22% w/v PEG-3350. Typically, diamond-shaped (MIM-1) or plate-
like (MIM-2) crystals began to form after seven days and continued to grow for the next 6 days 
(Figure 4.1). After this period, the crystals began to decompose and were no longer suitable for 
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crystallographic study. The crystals were thus cryoprotected in a mixture of 20% glycerol added to 
the precipitant buffer.  
 
Crystallographic data were collected by remote access on beamline MX-2 at the Australian 
Synchrotron (Melbourne) using BLU-ICE (179). The data were integrated, scaled and merged using 
HKL-2000 (180). Refinement and model building were carried out using PHENIX 1.8.4 (181) and COOT 
0.7 (182), respectively, using the previously published coordinates for Adelaide-IMipenemase-1 (AIM-
1; see also Chapter 5) from P. aeruginosa (4AWY) (7). All atoms were subsequently refined with 
anisotropic B-factors; most hydrogen atoms were fitted as riding models, though the proton of the 
bridging hydroxide was added manually based on the electron density. Relevant crystallographic data 
and refinement statistics are summarized in Table 4.1. 
 
  
Figure 4.1: Typical diamond-shaped crystal obtained for MIM-1 (left). Characteristic plate-like crystals obtained for 
MIM-2. 
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4.5 Results and discussion 
4.5.1 Protein purification and crystallography 
Recombinant MIM-1 and MIM-2 were expressed in E. coli BL21(DE3) and purified using a protocol 
previously established by our group (26). Importantly, the mature proteins had no N-terminal signal 
peptides, thus preventing their secretion into the periplasma. Both proteins crystallised over a period 
of approximately eight days.  
 
For MIM-1 the large diamond-shaped crystals (Figure 4.1) diffracted to 2.6 Å and were of space 
group P 41 21 2. Molecular replacement showed the presence of a single molecule occupying each 
asymmetric unit (Table 4.1). The overall structure of MIM-1 consists of a well-defined electron 
density map containing 274 amino acid residues (out of 300 in total for the full length enzyme), 
allowing for an uninterrupted trace of the polypeptide backbone from Pro33 to Ala305. Also present 
are the two catalytically important Zn2+ ions with occupancies of 1.0 each, along with a citrate 
molecule, which was a component of the crystallisation buffer. The Ramachandran plot shows that 
most of the residues (93.73%) are within the favoured regions, whilst another 1.97% are within the 
allowed region.  
 
For MIM-2 the plate-like crystals (Figure 4.1) diffracted to a resolution up to 1.8 Å and have the 
space group P 2 21 2, also with only one molecule per asymmetric unit. The structure of MIM-2 is 
well defined in the electron density map resolved for 264 residues (out of 295 in total for the full 
length enzyme), allowing for an interrupted trace of the polypeptide backbone from Thr31 to Ala300. 
However, the electron densities for the side chains of Ala160 to Leu161 and Glu207 to Arg210 are 
not clearly identifiable, hence, these residues are not present in the final structure. Also present are 
two Zn2+ ions, defining the catalytically relevant active site with an occupancy of 1.0 each (Figure 
4.3). A Ramachandran plot shows that 94.19% of all residues are within the favoured regions whilst 
another 4.26% are within allowed regions. The Patterson analysis function in Xtriage indicates a 
significant off-origin peak that is 20.8% of the magnitude of the origin peak. This observation strongly 
suggests the presence of pseudo-translational symmetry within the data.  
 
The refined overall structures of MIM-1 and 2 are shown below in Figure 4.2, along with the 
structures of the MBLs AIM-1, L1, SMB-1 and FEZ-1 for comparative purpose.  
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Table 4.1: Crystallographic data collection data and refinement statistics for MIM-1 and MIM-2. 
Diffraction data MIM-1 MIM-2 
    Resolution Range (Å) 48.06- 2.6 42.83- 1.84 
    Observations (I>(I))a 230230 (27609) 216935 (9576) 
    Unique reflections 
 (I>(I)) 
16484 (1964) 24468 (1318) 
    Completeness (%) 99.9 (99.6) 99.3 (88.2) 
    Mean <I/(I)> 21.8 (2.2) 7.5 (2.2) 
    Rmerge 0.0.078 (1.014) 0.168 (0.536) 
    Rpim 0.022 (0.278) 0.06 (0.205) 
    Multiplicity 14.0 (14.1) 8.9 (7.3) 
Crystal parameters   
    Space group P 41 21 2 P 2 21 2 
    Unit cell lengths (Å) a = 67.96 b = 67.96 c 
= 216.67 
a = 51.67 b = 69.53 c = 
76.54 
    Unit cell angles (°) α = 90 β = 90 γ = 90 α = 90 β = 90 γ = 90 
Refinement   
    Rwork
b 0.1728 0.2602 
    Rfree
b  0.2194 0.3090 
    rmsd bond lengths (Å) 0.0062 0.0019 
    rmsd bond angles (o) 0.860 0.568 
Ramachandran plot 
statistics 
  
    Favoured regions 93.73 94.19 
    Outlier regions 0.37 1.55 
 
4.5.2 Overall structure of MIM-1 and MIM-2 
The overall folds of MIM-1 and MIM-2 consist of an / motif that is characteristic for MBLs, 
with the hydrophilic  helices exposed to the solvent and the central core formed by two -sheets 
composed of five and seven  strands (Figure 4.2). Specifically, both MIM-1 and 2 include thirteen 
B-sheets with seven antiparallel strands at the N-terminus (B1-B7) and five antiparallel sheets at the 
C-terminus. Additionally, the MIM-1 structure also contains six α helices, two 310 helices (η1 and 
η2) and a citrate molecule bound within the active site. In contrast, the MIM-2 structure also contains 
8 α helices and three 310 helices (η1 to η3) as can be seen in the sequence alignment presented in 
Appendix A.  
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The active site groove is defined by two loops which are located at the interface of the two  domains 
and houses amino acid residues that are pivotal to the binding of substrates (Figure 4.4). Housed 
within the active site are two Zn ions whose amino acid coordination’s are identical to those of B3-
type MBLs (see below for details) (7,70).  Other interesting features include the presence of a Gln 157 
residue located on loop 1 (Figures 4.3 and 4.4) and the presence of a third disulphide bridge which 
binds the extended N-terminus away from the active site, creating an open and accessible active site 
pocket capable of housing even the bulkiest substrates (Figures 4.5 and 4.6). These features are 
suggested to increase the ability of theses enzymes to hydrolyse a wide range of substrates and is 
discussed in detail below. 
 
 
Figure 4.2: Overall structures of MIM-1 and MIM-2 with secondary structures coloured orange for helix and blue for 
sheet regions. For comparison the structures of the B3-type MBLs BJP from B. japonicum (PDB 3LVZ), AIM-1 from P. 
aeruginosa (PDB 4AWY), SMB-1 from S. marcescens (PDB 3VPE) and L1 from S. maltophilia (PDB 1SML) are also 
shown. All enzymes contain the characteristic αβ/βα structural motif, with the catalytically relevant metal ion centre 
located in the middle. The Zn2+ ions are shown as red spheres. The figure was generated using CCP4MG 
(http://www.ccp4.ac.uk/MG/). 
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4.5.3 Zn binding and active site 
The zinc binding site in MIM-1 and MIM-2 is defined by the HXHXDH sequence motif, which is a 
characteristic motif for the core of the binuclear metal ion binding site in the MBL superfamily (7). 
Thus, not surprisingly the coordination of the zinc ions in the active site of MIM-1 and MIM-2 closely 
resembles that observed for other MBLs, especially those of the B3 subgroup (Figure 4.3). The Zn-
Zn distances in MIM-1 (4.02 Å) and MIM-2 (3.40 Å) are comparable with those observed in BJP-1, 
FEZ-1, L1 and AIM-1 structures (Table 4.2) (7,122,130,133). The increased distance between the metal 
ions in MIM-1 is likely due to interactions with the bound citrate molecule, who’s carboxyl oxygens 
are seen to occupy the positions of W1, W2 and W3 seen for MIM-2.  
 
 
 
Figure 4.3: Active site structures of MIM-1 (left) and MIM-2 (right), including Gln157 in both enzymes and Arg46 (for 
MIM-1 only), which may play an important role in substrate binding (see text for details).  In MIM-1 a molecule of citrate 
(a component of the crystallisation solution) is present in the active site with carbonyl oxygens occupying the positions 
of W1, W2 and W3 seen for MIM-2. 
 
Generally, the active sites of all known B3-type MBLs, including the two MIM proteins, are highly 
conserved. For MIM-1 and MIM-2 the metal ion in the Zn1 site is coordinated in a tetrahedral 
conformation by His116, His118 and His194 (the His site), while the Zn2 site adopts a rather trigonal 
bipyramidal geometry, formed by residues Asp120, His121 and His260 (His259 in MIM-2). Relevant 
Zn-ligand distances are summarised in Table 4.2. It is interesting to point out that in MIM-1, unique 
among MBLs, an arginine residue (Arg46) located on the hairpin leading toward the N-terminus, is 
within close proximity to the active site (Figure 4.3). Although it has yet to be determined, it is 
possible that this side chain may play a role in the recognition of substrates for this enzyme. Directed 
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mutagenisis experiments on this residue may determine the impact, positive or negative, that this 
residue imposes upon the binding of substrates.  
  
Table 4.2: Selected distances between the zinc ions and their ligands in the active sites of MIM-1 and MIM-2. 
Interaction partner MIM-1  MIM-2  
Zn1   
His 116 2.09 Å 2.20 Å 
His 118 1.91 Å 2.03 Å 
His 194 2.08 Å 2.03 Å 
W1 - 1.96 Å 
W2 - 3.07 Å 
O4 (displaced W1) 2.58 Å - 
O3 (displaced W2) 2.70 Å - 
Zn2 
 
 
Asp 120 2.34 Å 2.03 Å 
His 121 1.97 Å 2.21 Å 
His 260 2.00 Å 2.10 Å 
W1 - 1.99 Å 
W3 - 2.02 Å 
O4 (displaced W1) 1.86 Å - 
O1 (displaced W3) 2.18 Å - 
Zn1-Zn2 4.02 Å 3.40 Å 
 
 
The active site pocket of B3 MBL is largely defined by two loops that house the residues responsible 
for substrate recognition and binding. The backbone trace of the loop 1 and 2 regions for the MIM 
proteins is highly conserved with Aim-1 and SMB-1 yet differs from other members of the B3 
subclass.  Previously published directed mutagenesis and substrate co-crystallisation studies, have 
illustrated that residues Gln157 (located on loop 1), Ser221 and Thr223 (both located on loop 2) play 
a role in substrate recognition (7,71,213). These residues are mostly conserved between the MIM proteins 
(Thr223 is replaced by Ser 223 in MIM-1), AIM-1 and SMB-1 however some small changes in 
geometry are evident.   
 
Interestingly, it has been proposed that the presence of a Gln157 residue only occurs in MBLs that 
were acquired via horizontal gene transfer, but is not present in MBLs that are located on 
chromosomes (i.e. such as L1, BJP or FEZ-1) (70,130,133). Thus, it seems likely that the MIM proteins 
are indeed located on a mobile genetic element and were acquired through horizontal gene transfer.  
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Figure 4.4: Loop 1 and 2 regions for selected MBL MIM-1 (orange), MIM-2 (blue), AIM-1 (green)(7), L1 (lilac)(122), 
SMB1 (yellow)(71) and BJP (grey)(130). Important residues for substrate binding are also shown for the MIM proteins. 
4.5.4 Disulphide bridges 
Intramolecular disulphide bonds play an important role in protein folding and stability. Majority of 
B3 MBL poses at least one disulphide bond. In both of the MIM proteins three disulphide bridges are 
present (Figure 4.5). The Cys253-Cys282 and Cys252-Cys281 pair in MIM-1 and MIM-2, 
respectively, is also present in majority of B3-type MBLs. The two additional disulphide bonds 
(Cys40-Cys68, Cys206-Cys212 and Cys43-Cys68, Cys206-Cys211 in MIM-1 and MIM-2, 
respectively) are present in AIM-1 and SMB-1 but no other B3-type MBLs (7). In particular, the 
Cys40-Cys68 (MIM-1) or Cys43-Cys48 (MIM-2) disulphide bridge directly affects the folding of the 
extended N-terminus in these enzymes. This bridge links the η1 helix with the β2 strand, causing the 
extended N-terminus to fold away from the active site (Figure 4.6). Similar B3 MBL that share this 
feature (Eg AIM-1, SMB-1) tend to have higher activity than those whose N-terminus enters or 
imposes on the space available within the active site (eg. BJP and RM3) (70,71,130,135). With this theme 
in mind, it has been shown that the L1 protein also gained a reduction of the Kcat/km by at least 20-
fold when its extended N-terminus was truncated such that it no longer imposed on the active site 
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(126). Thus, it appears as though this feature is beneficial for the promiscuous catalytic activity of these 
enzymes, facilitating access for substrates with bulky functional groups (7).   
 
 
Figure 4.5: MIM-1 (top) and MIM-2 (bottom) have three disulphide bridges (shown with associated electron densities). 
 
Figure 4.6 The extended N-terminus for BJP (left), MIM-1 (middle) and MIM-2 (right), illustrating the open active site 
of the MIM proteins in contrast to BJP, who’s active site is blocked by the N-terminus..  
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4.6 Conclusion 
In this Chapter, the crystal structures of two novel B3-type MBL-like enzymes from environmental 
(i.e. non-pathogenic) microorganisms are described. Indeed, MIM-1 and MIM-2, are closely related 
in structure to AIM-1, a B3-type MBL identified in a strain of P. aeruginosa that is resistant to most 
commonly used antibiotics (see also Chapter 5) (7). This observation may not be surprising 
considering that the amino acid sequence of AIM-1 was used as a query sequence to identify MIM-1 
and MIM-2 (25). Although little is known about the genetic make-up of the host organisms of MIM-1 
and MIM-2 (i.e. N. pentaromativorans and S. agarivorans, respectively) the structural similarity to 
AIM-1 suggests that the two novel MBL-like enzymes may be located on mobile genetic elements. 
Considering the considerable catalytic efficiency and broad range of substrates of MIM-1 and MIM-
2 these enzymes may thus present a real threat to health care (26,212).  
 
Both MIM-1 and MIM-2 have the / fold characteristic for all MBLs. Generally, the loop regions 
and substrate binding residues are conserved between the MIM proteins and other B3 MBL. 
Interestingly, residue Gln157, which has only been seen in AIM-1 and SMB-1, is positioned close to 
the catalytic bimetallic metal ion centre where it is likely involved in interactions with the carbonyl 
group of the -lactam ring, thus enhancing the electrophilicity of the substrate. Furthermore, the 
presence of additional disulphide bridges was seen to enlarge the active site through binding the 
extended N-terminus away from the active site. The combination of all these features are likely 
essential factors contributing to the promiscuous functionality of MIM-1 and MIM-2. With this 
knowledge, these enzymes may provide clues as to how to develop inhibitors that are not only potent 
in stopping β-lactamase activity, but that are also persistent. Studies towards this aim are currently in 
progress. 
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Figure 5.1: AIM-1 is a metallo-β-lactamase (MBL) with a broad substrate specificity. A range of physico-chemical 
techniques have been employed to demonstrate that both substrates and inhibitors may bind in different modes and 
locations to the enzyme.  The insight gained may pave the way for the development of clinically useful universal MBL 
inhibitors, an essential strategy to combat antibiotic resistance.  
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5.1 Abstract 
Antibiotic resistance has emerged as a major threat to global health care. This is largely due to the 
fact that many pathogens have developed strategies to acquire resistance to antibiotics. Metallo-β-
lactamases (MBL) have evolved to inactivate most of the commonly used β-lactam antibiotics. AIM-
1 is one of only a few MBLs from the B3 subgroup that is encoded on a mobile genetic element in a 
major human pathogen.  Here, its mechanism of action was characterised with a combination of 
spectroscopic and kinetic techniques and compared to that of other MBLs.  Unlike other MBLs it 
appears that AIM-1 has two avenues available for the turnover of the substrate nitrocefin, 
distinguished by the identity of the rate-limiting step.  This observation may be relevant with respect 
to inhibitor design for this group of enzymes as it demonstrates that at least some MBLs are very 
flexible in terms of interactions with substrates and possibly inhibitors. 
5.2 Keywords:  
Antibiotic resistance, β-lactam antibiotics, metallo-β-lactamase, imipenemase, metalloenzyme 
5.3 Introduction  
β–Lactamases are a class of enzymes that catalyze the hydrolysis of the four-membered β-lactam 
ring, the characteristic feature of many commonly used antibiotics such as penicillins, carbapenems, 
cephalosporins and monobactams (Figure 5.2).  These compounds are very effective in impeding the 
enzymes involved in the generation of peptidoglycans in the cell wall of pathogenic bacteria 
(16,150,156,208). 
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Figure 5.2: Illustration of the four major groups representing the family of β-lactam antibiotics. 
 
β-Lactamases are divided into two main classes based on their mechanism of action and cofactor 
requirements (15,16,150,156,208).  These include the serine-β-lactamases (SBLs), which employ a serine 
residue to initiate the hydrolysis of the β-lactam ring (i.e. its opening), and metallo-β-lactamases 
(MBLs), which require either one or two metal ions in their active site as essential cofactors for 
catalysis (15,16,150,156,208).  MBLs are further sub-divided into as many as four sub-groups, i.e. B1, B2, 
B3 and B4, depending on their sequence homology and metal ion requirements.  However, all MBLs 
do share a characteristic αββα fold (as discussed in Chapter 1) (15,16,150,156,208,214).  
 
MBLs from the B1 subgroup generally require two Zn2+ metal ions for catalytic activity 
(15,16,150,156,208,214), although at least the MBL from Bacillus cereus (BcII) was shown to be partially 
active in its mononuclear form (151).  In contrast, B2-type MBLs require only one metal ion in their 
active site for optimal catalytic activity; the binding of a second metal ion leads to the inactivation of 
the enzyme (215).  These MBLs are also more selective in terms of their preferred substrates displaying 
specific activity towards monobactams (Figure 5.2), a group of antibiotics that are poor substrates for 
other MBLs (215).  B3-type MBLs are similar to B1 enzymes in that they require two metal ions in 
their catalytic site to be fully active, however their active site architecture is quite different (216); whilst 
B1- and B3-type MBLs have identical ligands for one of the two Zn2+ binding sites (the Zn1 site; 
Figure 5.2), they differ in the other metal centre (the Zn2 site; Figure 5.3) (16,150,156,208,216).  
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Figure 5.3: Active site structure of AIM-1. Two Zn2+ ions (grey spheres) are bound in the catalytic centre.  The Zn1 site 
contains the ligands His116, His118 and His196 and is conserved in B1- and B3-type MBLs.  The Zn2 site is made up of 
ligands Asp120, His121 and His263 and is different from the corresponding centre in B1-type MBLs.  In addition, two 
water molecules (red spheres) complete the coordination spheres, one bridging the metal ions and one terminally 
coordinated to Zn2.  Consequently, the two Zn2+ ions are four- and five-coordinate, respectively.  The coordinates for the 
structure were taken from the PDB file with accession code 4AWY (216) 
 
The remaining available coordination positions in both groups of enzymes are occupied by water 
molecules, including one that bridges the two Zn2+ ions. This water molecule is the likely nucleophile 
that initiates the hydrolysis of the β-lactam substrates (15,16,150,208).  No structural information has yet 
been reported for a member of the B4 subgroup, but catalytic data reported for the putative B4 MBL 
from Serratia proteamaculans (SPR-1) suggest that in its resting form this enzyme may be 
mononuclear and inactive, but that the addition of a substrate promotes the binding of a second metal 
ion, leading to the formation of a catalytically active dinuclear metal centre (217). This substrate-
promoted activation mechanism resembles that of another metallohydrolase, the organophosphate-
degrading glycerophosphodiesterase from Enterobacter aerogenes, GpdQ (218-220). 
 
Clinically, the capacity for β-lactamases to hydrolyse a wide range of β-lactam antibiotics represents 
a significant threat to global health (150,156).  In the case of SBLs, there are clinically useful inhibitors 
available, in particular clavulanic acid (221).  The co-administration of clavulanic acid with an 
antibiotic is a common practice to circumvent resistance (221).  In stark contrast, there are currently no 
clinically viable inhibitors available for MBLs.  This, together with the fact that many MBLs are 
encoded on mobile genetic elements (plasmids, transposons) make them extremely dangerous agents 
(158,222,223).  MBLs can easily be “shared” between bacterial species, accelerating the spread of 
resistance dramatically (16,150,156,158,208,222-225). 
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An imipenem-degrading enzyme, initially identified in a pathogen in a hospital in Adelaide, Australia, 
and hence labelled Adelaide Imipenemase-1 (AIM-1), is a member of the B3 subclass of MBLs 
(158,216).  To date, AIM-1 is one of only a few members of the B3 subgroup that is encoded on a mobile 
genetic element in a major human pathogen (the Gram-negative Pseudomonas aeruginosa); the 
majority of B3-type MBLs have been found in environmental bacteria (158).  AIM-1 has the capacity 
to hydrolyse a broad spectrum of β-lactam antibiotics (158).  The crystal structure for wild-type AIM-
1 (Figure 5.3) has been previously reported along with a preliminary characterisation of its catalytic 
parameters and substrate specificity (158,216).  Here, we employed a range of physico-chemical 
techniques to probe its reaction mechanism, with a particular view on highlighting variations that 
distinguish AIM-1 from other MBLs. 
5.4 Results  
5.4.1 Characterisation of the steady-state catalytic parameters of AIM-1 
The substrate specificity of AIM-1 was probed previously, indicating that the enzyme is a broad-
spectrum MBL (158).  At pH 7.5 the kcat and kcat/Km for ampicillin, meropenem, cefuroxime and 
nitrocefin are 123.0(0.2) s-1 and 8.3(0.5) x 104 s-1M-1, 372.1(0.3) s-1 and 8.2(0.4) x 104 s-1M-1, 
93.1(0.7) s-1 and 4.2(0.3) x 106 s-1M-1, and 240 (2) s-1 and 2.5 (0.7) x 106 s-1M-1, respectively, in 
reasonable agreement with values published previously for AIM-1 (no prior data for nitrocefin were 
available) (158).  We noted that for some substrates, independent of pH, high concentrations lead to a 
decrease of the catalytic activity (i.e. the rate vs [S] profiles deviate from Michaelis-Menten-type 
behaviour at high [S]; see [Equation 5.1] in the Experimental section and Figure 5.4.  A similar 
observation was previously noted for the MBLs MIM-1 and MIM-2 (both belonging to the B3 
subgroup) and CcrA from Bacteroides fragilis (representing the B1 subgroup) (226,227).  The estimated 
substrate inhibition constant Ki (using [Equation 5.2] is 106(10) μM, 202(50) μM and 87(15) μM for 
ampicillin, meropenem and cefuroxime, respectively, in reasonable agreement with Ki values reported 
for MIM-1 or MIM-2 (no substrate inhibition was observed with nitrocefin) (227). 
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Figure 5.4: Rate vs substrate concentration profile for the hydrolysis of cefuroxime by AIM-1.  Qualitatively similar data 
were obtained for ampicillin and meropenem.  At high substrate deviations from Michaelis-Menten behaviour were 
observed.  Each data set was thus analysed for low cefuroxime using the Equation 5.1 and for the entire range of substrate 
using Equation 5.2.  The reaction with nitrocefin displayed Michaelis-Menten-type behaviour over the entire substrate 
range tested. 
 
A similar behaviour was also observed for the reaction with the substrate biapenem, a compound that 
is structurally related to meropenem (Figure 5.2).  Again, high concentrations of the reactant lead to 
deviation from Michaelis-Menten-type behaviour (Figure 5.5).  However, uniquely for this reactant 
increasing concentrations of the substrate also lead to an increasing lag period before the steady-state 
rate is reached (Figure 5.5).   
 
 
Figure 5.5: The activity vs [Biapenem] plot also illustrates a deviation from Michaelis-Menten-type behaviour at high 
substrate concentrations (left).  Relevant catalytic parameters are kcat = 235(62) s-1, kcat/Km = 8.1(1) x 105 s-1M-1 and 
Ki = 906(452) µM.  Furthermore, the higher the substrate concentration, the longer is the lag time before steady-state 
rates are attained (right). 
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The effect of pH on the catalytic properties of wild-type AIM-1 towards the selected subset of 
substrates representing major classes of β-lactam antibiotics (i.e. ampicillin, meropenem, cefuroxime 
and nitrocefin) was carried out to gain insight into catalytically relevant protonation equilibria.  
Measurements were carried out at suitably low substrate concentrations to minimise the inhibitory 
effect of the reactants.  The pH dependence of kcat and kcat/Km were analysed independently since they 
provide information about catalytically relevant protonation equilibria (i.e. pKa values) of the 
enzyme-substrate (ES) complex, or free enzyme (E) or substrate (S), respectively (228).  For none of 
the four substrates tested did the kcat/Km ratio display pH dependence in the range between pH 6 to 10 
(data not shown).  In contrast, the catalytic rate (kcat) is dependent on pH, but the effect is substrate 
specific (Figure 5.6).   
 
Figure 5.6: pH dependence of the catalytic activity (kcat) of AIM-1 for the hydrolysis of the following substrates: 
meropenem (circle), cefuroxime (hexagon), ampicillin (open triangle) and nitrocefin (open square). 
 
For ampicillin and cefuroxime the effect of pH on kcat is modest; while a deprotonation event leads to 
an increase in the reactivity towards ampicillin the opposite effect is observed for cefuroxime.  An 
effect similar to that for cefuroxime is also observed for meropenem although the loss of activity with 
increasing pH is more significant.  The slopes of the curves shown in Figure 5.6 are an indication of 
the presence of a protonatable residue that may contribute to the rate-limiting step of the reaction – a 
slope close to unity indicates that the residue is directly associated with the rate-limiting step, whereas 
the other extreme (i.e. pH independence indicated by a slope of zero) indicates that the respective 
residue is not involved in determining the overall rate of the reaction (228). The pKa values for the 
reactions with these three substrates (i.e. pKes values) were estimated by fitting the data to an equation 
derived for a monoprotic model (Equation 5.3).  Table 5.1 summarises relevant parameters.  The pH 
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dependence of the reaction with nitrocefin is more complex displaying both an acidic (as observed 
with ampicillin) and an alkaline limb (as observed with meropenem and cefuroxime; Figure 5.6).  The 
slopes of both limbs are close to unity indicating that at least two protonizable residues play an 
essential role in the AIM-1-catalyzed hydrolysis of nitrocefin.  The profile adopts a characteristic 
bell-shaped curve and was fitted to Equation. 5.4; maximum activity is reached around pH 7.5-8. 
 
Table 5.1: Catalytically relevant protonation equilibria for the AIM-1-catalysed hydrolysis of a range of substrates.  pKes1 
and pKes2 represent the acid dissociation constants of the enzyme-substrate complexes associated with the acidic and 
alkaline limbs of the pH profiles, respectively.   
 Ampicillin Cefuroxime Meropenem Nitrocefin 
pKes1 6.9(0.2) - - 6.7(0.4) 
pKes2  7.7(0.4) 9.4(0.8) 8.9(0.2) 
 
 
D-Captopril is a known non-clinical, competitive MBL inhibitor with inhibition constants ranging 
from ~6 μM for MIM-1 (representing the B3 subgroup) to ~70 μM for CphA (a B2 subgroup MBL) 
(227).  The inhibitory effect of captopril on AIM-1 is similar to that reported for other MBLs from the 
B3 subgroup (Figure 5.7), although the best fit to the kinetic data suggests that two modes of inhibitor 
binding may be possible.  The dominant mode of inhibition is competitive (Kic ~ 19 µM), with an 
uncompetitive mode being approximately an order of magnitude weaker (Kiuc ~ 137 µM).  Since the 
uncompetitive mode of binding has an affinity similar to that of the substrate inhibition constant 290 
µM for cefuroxime; (vide supra) it is likely that captopril competes with the substrate for both its 
catalytically relevant and inhibitory sites.  Interestingly, Cu2+ exerts an inhibitory effect on AIM-1 
activity, which also has a competitive (Kic = 11.9 µM) and uncompetitive (Kiuc = 35.5 µM) component 
(Figure 5.7).  
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Figure 5.7: Inhibition of AIM-1 by Cu2+ (left) and captopril (right).  The different concentrations of inhibitor tested for 
Cu2+ are zero (open circle), 0.04 µM (squares), 10 µM (open triangles), 20 µM (circles) and 30 µM (open diamonds). For 
captopril the concentrations are zero (open circle), 50 µM (squares), 100 µM (open triangles), 200 µM (circles) and 400 
µM (open diamonds). 
5.4.2 Metal ion replacement studies 
Metal ion replacement studies with metalloenzymes frequently provide valuable catalytic insight, but 
the derivatives may also be useful for spectroscopic studies, in particular if a spectroscopically silent 
metal ion (e.g. Zn2+) is replaced by a paramagnetic one (e.g. Co2+).  Here, the native Zn2+ ions could 
be easily removed from AIM-1 by incubation with a chelator solution.  The apoform remained intact 
since the subsequent addition of Zn2+ led to a full reconstitution of the catalytic activity (data not 
shown).  In a parallel experiment the apoenzyme was incubated with Co2+.  The catalytic parameters 
of the Co2+-derivative of AIM-1 for the hydrolysis of cefuroxime at pH 7.5 are kcat = 50.5 s
-1 and Km 
= 58.6 µM, compared to kcat = 93.1 s
-1 and Km = 21.2 µM determined for the native Zn
2+-form under 
identical conditions (Figure 5.8).   
 
Figure 5.8: Comparison of the enzymatic activities of the Co2+- and Zn2+-derivatives of AIM-1 (open circles and squares, 
respectively) for the hydrolysis of the substrate cefuroxime. 
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The stoichiometry and binding affinities of these two metal ions were determined using isothermal 
titration calorimetry (ITC) (Figures 5.9 and 5.10).  Two Zn2+ ions bind with similar affinity (~170 
nM; Table 5.2).  In contrast, only one site binds Co2+ with high affinity (~7 nM), while the other site 
has a considerably weaker affinity (~2 µM).  
 
Figure 5.9: Representative ITC data for the interactions between AIM-1 (33 µM) and aliquots of 5 mM stock solutions 
of ZnCl2 (left) and CoSO4 (right).  The data were fitted using a two-independent-binding-sites model. 
 
Table 5.2: Stoichiometry and binding constants obtained from an ITC experiment whereby Zn2+ or Co2+ were added 
gradually to the apoform of AIM-1. 
 Zn2+ Co2+ 
 Site 1 Site 2 Site 1 Site 2 
nITC 1.5(0.3) 1.3(0.2) 1.0(0.5) 0.9(0.2) 
KITC (M-1) 4.15(1.1)x10
6 4.1(0.9) x106 1.14(0.2)x108 3.77(0.7)x105 
Kaff (M-1) 5.69(0.2)x10
6 5.70(0.1) x106 1.40(0.2)x108 4.6(0.4)x105 
Kd (μM) 0.17(0.05) 0.17(0.06) 0.0071(0.001) 2.16(0.3) 
ΔG (kcal/mol ) -8.99 -9.02 -11.1 -7.72 
aThe robustness of the fits was tested by using a range of initial guess values including the optimised 
parameters from the Zn2+ titration for the Co2+ data set and vice versa.  Independent of the initial 
guess the fits converged to the same optimised parameters. 
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Figure 5.10: The error associated with each of the injections in the ITC experiments shown in Figure 5.9 were estimated 
using the Affinimeter software (https://www.affinimeter.com/). 
5.4.3 Spectroscopic characterisation of the AIM-1 active site 
The Co2+-derivative of AIM-1 is well suited to investigate the catalytic centre of an active MBL using 
spectroscopic techniques.  Here, magnetic circular dichroism (MCD) and continuous wave electron 
paramagnetic resonance (cwEPR) were employed to probe (i) the coordination environment of the 
metal centre in the resting, free enzyme and (ii) the effect (if any) of the inhibitor D-captopril on this 
centre.   
 
Figure 5.11: MCD spectrum (7 T) at 1.4 K of free AIM-1. Inset: the spectrum free AIM-1 (black) is compared with that 
recorded in the presence of D-captopril (blue). 
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The MCD spectrum of resting AIM-1 (Figure 5.11) could be fit to no fewer than six transitions 
between 450 and 600 nm.  Calculations using the angular overlap model (AOM) were used to assign 
the individual transitions as described in detail elsewhere (218,220,229-232).  The coordinates for the 
calculations were taken from the crystal structure (PDB code: 4AWY (216)) and each Co2+ site was 
treated separately.  The Racah parameters C and B were fitted individually and with C = 4.7B.  The 
calculations indicate that the six transitions originate from two six-coordinate Co2+ species (Table 
5.3). 
 
Table 5.3:  Summary of ligand field calculations 
 
 
 
6-coordinate 
Species 
Origin in Oh d-d transition (nm) 
 Observed Calculated 
𝑇1𝑔 → 𝑇1𝑔(𝐺)
24  474 469 
𝑇1𝑔 → 𝑇1𝑔(𝑃)
44  489 495 
𝑇1𝑔 → 𝑇1𝑔(𝑃)
44  504 503 
𝑇1𝑔 → 𝑇1𝑔(𝑃)
44  517 516 
𝑇1𝑔 → 𝑇1𝑔(𝑃)
44  529 525 
𝑇1𝑔 → 𝐴2𝑔
44  551 549 
 
   
Table 5.4:  Spectroscopic parameters obtained from fitting VTVH MCD data collected in the absence or presence 
of the inhibitor D-captopril 
 AIM-1 AIM-1 + captopril 
nm 491 504 491 504 
J 0.12 cm-1 0.11 cm-1 0.20 cm-1 0.12 cm-1 
D  50  50  50  50 
D 5.6 cm
-1 5.5 cm-1 4.8 cm-1 5.1 cm-1 
E 0 0 0 0 
 
This observation contrasts the coordination environment of the two Zn2+ ions in the crystal structure 
of AIM-1 (Figure 5.3) and suggests that in the Co2+ derivative additional water molecules may 
complete the coordination sphere of the two metal ions.  The addition of captopril to the resting 
enzyme quenches the observed MCD intensity slightly but does not affect the individual transitions 
associated with the two metal ions (Figure 5.11, inset).  It thus appears that D-captopril binding does 
not perturb the electronic structure of the dinuclear Co2+ centre significantly, an interpretation that is 
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in agreement with cwEPR data (see below).1   Variable temperature, variable field (VTVH) MCD 
data for the transitions at 489 nm and 504 nm (Figure 5.12) were analysed using the dimer model (229).  
Both transitions originate from the Oh low symmetry splitting of the 𝑇1𝑔
4 → 𝑇1𝑔
4 (𝑃) energy levels.  
Relevant parameters are summarised in Table 5.4, and indicate that the two Co2+ ions have axial 
geometry (E/D ~0) and are weakly ferromagnetically coupled, independent of the presence of D-
captopril, with an exchange coupling constant J estimated to ~0.1-0.2 cm-1. 
 
 
Figure 5.12: VTVH MCD data for the 489 nm and 504 nm transitions.  Data were recorded at the following temperatures: 
1.4, 3, 6, 12, 24 and 48 K (black, red, green, blue and yellow, respectively). 
 
Figure 5.13: X-band cwEPR spectra of AIM-1 (top, black), AIM-1 + D-captopril (middle, blue), and a simulation 
assuming an effective S = 3/2 spin (bottom, red).  Measurement conditions: T = 20 K, microwave power = 20 mW, 
modulation amplitude = 1 mT, modulation frequency = 100 kHz, microwave frequency = 9.619 GHz. 
                                                 
1 An alternative explanation is that D-captopril occupies only a fraction of the available binding sites and induces strong 
antiferromagnetic coupling, leading to a reduction of the observed paramagnetism. However, with an estimated inhibition 
constant of ~20 μM it is estimated that the more than 500-fold excess of inhibitor will lead to almost complete saturation 
of the active sites. 
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EPR spectra for the Co2+-derivative of AIM-1 were recorded as a function of microwave power in 
the absence and presence of D-captopril in both perpendicular and parallel mode (Figures 5.13 and 
5.14). The representative spectra are shown in Figure 5.13, with and without the inhibitor D-captopril, 
and are very similar, a result consistent with the MCD data.  This indicates that the interaction of the 
inhibitor with the paramagnetic centres is weak and below detection limits, probably as a result of the 
large linewidth of the cwEPR spectra.  The data were simulated employing a Spin Hamiltonian model 
with an S = 3/2 spin, where the zero-field splitting is much greater than the electron Zeeman 
interaction, i.e. D >> βgBS (in agreement with MCD data; Table 5.4).  This model assumes that the 
interaction between the two Co2+ centres is small and below the large cwEPR linewidth.  Optimisation 
of the principal g-values and the corresponding linewidths yielded the estimates g = 2.35, g = 1.0, 
and g = 2.30, g = 0.9, where D was found to be positive.  Consequently, the EPR signal arises 
from transitions between the Ms = ±½ electron spin manifolds.  The rhombicity of the zero-field 
splitting was found to be small, E/D < 0.03, again in good agreement with the MCD data.  These 
parameters, in particular the sign of D, are indicative of a five- or six-coordinate Co2+ complex (128).  
The EPR spectra and parameters for AIM-1 are similar to those from NDM-1, Bla2 from Bacillus 
anthracis and L1 from Stenotrophomonas maltophilia when loaded with two Co2+ ions (128,233). 
 
 
(A.1) AIM-1 at 20K, perpendicular mode
 
(A.2) AMI-1 at 20K parallel mode
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(A.3) AIM-1, 4.5K, perpendicular mode
 
(A.4) AMI-1 at 4.5K parallel mode
 
  
(B.1) AIM-1 + captopril, 20K, 
perpendicular mode
 
(B.2) AMI-1 + captopril, 20K, parallel 
mode
 
(B.3) AIM-1 + captopril, 4.5K, 
perpendicular mode
 
(B.4) AMI-1 + captopril, 4.5K, parallel 
mode
 
 
Figure 5.14:  cwEPR spectra of AIM-1 without (A) and with (B) D-captopril measured at 4.5 K and 20 K, and at a range 
of microwave powers as indicated.  Qualitatively similar results were obtained in both perpendicular and parallel modes. 
In perpendicular mode the cwEPR spectra at 20 K were not saturated (spectrum strength increases linearly with the square 
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root of the microwave power) over the range of microwave power, whereas at 4.5 K the spectrum at the highest microwave 
power of 20 mW (10dB) is saturated. In parallel mode no saturation is observed. 
 
Since Cu2+ has an inhibitory effect on AIM-1 activity, displaying both a competitive and 
uncompetitive binding mode (see above and Figure 5.7) the EPR spectrum of the catalytically inactive 
Cu2+ derivative of AIM-1 was recorded to assess if two metal ions may bind in close vicinity (Figure 
5.15). The lack of an apparent EPR signal indicates that the two Cu2+ ions are strongly 
antiferromagnetically coupled.  
 
Figure 5.15: X-band (9.43 GHz) cwEPR spectra recorded at 130 K using a microwave power of 6.315 mW (15 dB), 
modulation amplitude of 0.1 mT and a modulation frequency of 100 kHz. The Cu2+-loaded buffer is shown on top (cyan).  
In the middle (blue) a sample of apo-AIM-1 in the presence of excess Cu2+ is shown.  The spectrum on the bottom (red) 
was recorded for the enzyme sample after the removal of excess Cu2+ on a gel filtration column.  The lack of any signal 
is consistent with the presence of a strongly antiferromagnetically coupled dinuclear Cu2+ centre. 
5.4.4 Rapid kinetics measurements 
Pre-steady state kinetic data for the reaction of AIM-1 with the substrate nitrocefin were acquired in 
order to probe the initial phase of the catalytic cycle, but also to compare the mechanism of action 
with that of other MBLs, notably Bla2, NDM-1 and L1(128,233).  The reaction was monitored for 500 
ms using a diode array detector (Figure 5.16, top panel).  Three distinct transitions are observed; the 
bands at 390 nm and 485 nm are associated with intact and hydrolysed nitrocefin, respectively.  The 
feature at 665 nm was previously associated with the ring-opened anionic intermediate of the reaction 
(234).  The concentration of the reaction intermediate reaches a maximum after ~50 ms and is below 
the limits of detection after ~250 ms. Progress curves for substrate depletion (390 nm), product 
formation (485 nm), and the emergence and disappearance of the intermediate (665 nm) were 
63 
 
simulated using KIMSIM with the models A and B shown in Figure 5.16.  Suitable guess values were 
used as initial parameters for data fitting using the program FITSIM (235-237).  The values of k1 and k-
4 were set to the diffusion-controlled limit (10
8 M-1.s-1).  The remaining parameters obtained from a 
global analysis (using either Model A or B) are listed in Table 5.5.  The main difference between the 
two models is that the steps leading to the formation and decay of the intermediate (i.e. k2 and k3, 
Figure 5.16) are assumed reversible in Model A and irreversible in Model B (Model A has previously 
been employed to analyse comparable data for the MBLs L1 and NDM-1 (102,128)).  While the 
formation rate for the intermediate differs in the two models (~170 s-1 vs ~240 s-1 in Models A and 
B, respectively), the decay rate remains virtually unchanged (~22 s-1).  For comparison, corresponding 
values reported for the related B3 subgroup MBL L1 are 190 s-1 and 38 s-1, respectively (123).   
 
 
 
Figure 5.16: Rapid scan UV-Vis stopped-flow measurements at room temperature under single turnover conditions (10 
μM AIM-1 and 16 μM nitrocefin).  Experimental data are shown in the top row, recorded over a period of 0.5 s.  The 
experimental data were analysed using several mechanistic models (middle row), and the corresponding fits to the time 
course of the concentrations for the substrate (measured at λ = 390 nm), the product (λ = 485 nm) and the reaction 
intermediate (λ = 665 nm) are shown in the bottom row. 
E + S ES EP E + P
k1
k-1
k2
E + S ES EI EP
k1
k-1
k2 k3 k4
k-4
E + P
E + S ES EI EP
k1
k-1
k4
k-4
E + P
k2
k-2
k3
k-3
A
B
Ck4
k-4
0.0 0.1 0.2 0.3 0.4 0.5
0
5×10-6
1×10-5
Time (s)
C
o
n
c
e
n
tr
a
ti
o
n
 (
m
o
l/
L
)
A
0.0 0.1 0.2 0.3 0.4 0.5
Time (s)
C
0 0.1 0.2 0.3 0.4 5
Time (s)
B
64 
 
 
Table 5.5:  Rate constants for the reaction of AIM-1 with nitrocefin.  The rate constants were obtained using the 
mechanistic schemes illustrated in Figure 5.16.  kcat and KM represent the theoretical values calculated using the King-
Altman approach to derive rate equations for the reactions illustrated in Models A, B and C. 
 Model A Model B Model C 
k1 (M
-1 s-1) 1.0x108 1.0x108 1.0x108 
k-1 (s
-1) 1078(51) 18.7(5) 252.0(15) 
k2 (s
-1) 168.1(7) 238.4(10) 228.0(32) 
k-2  (s
-1) 0.2(0.1)   
k3 (s
-1) 22.8(3) 21.4(7)  
k-3 (s
-1) 0.5(0.3)   
k4 (s
-1) 3500(25) 184.8(12) 200(21) 
k-4 (M
-1 s-1) 1.0x108 1.0x108 1.0x108 
kcat (s
-1)a 20 18 106 
KM (µM) 1.7 50 30 
aThe corresponding kcat and KM values determined from 
steady-state measurements are 240 s-1 and 125 µM, 
respectively. 
 
The microscopic rate constants listed in Table 5.5 can be used to calculate theoretical values for kcat 
and Km employing equations derived using the approach by King and Altman 
(228).  For both NDM-1 
and L1 there is reasonable agreement between those theoretical values and the corresponding values 
measured in steady-state kinetic assays (102,128).  For AIM-1 neither model A nor Model B led to a 
good agreement between theoretical and experimental parameters (Table 5.5).  Indeed, using a model 
that by-passes the intermediate altogether (Model C in Figure 5.16) leads to theoretical kcat and Km 
values that are in far better agreement with the corresponding experimental parameters (Table 5.5).  
The same model was previously employed to analyse the catalytic parameters for Bla2, an MBL for 
which no intermediate during the turnover of nitrocefin (i.e. no spectral changes at ~665 nm) was 
observed (233). 
 
Previous studies with the MBLs NDM-1 and L1 demonstrated that fluorescence measurements may 
be used to monitor substrate binding (102,128).  The change in fluorescence during this reaction is 
associated with a tryptophan residue in the vicinity of the active site, i.e. Trp93 and Trp38 in NDM-
1 and L1, respectively.  This residue is conserved in AIM-1 (Trp38).  The corresponding fluorescence 
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progress curve for the reaction with nitrocefin, recorded under single turnover conditions, is shown 
in Figure 5.17.  A very rapid quench in fluorescence during the first ~10 ms of the reaction is followed 
by a slower recovery, complete after ~100 ms. The two transients were individually fitted to a single 
exponential resulting in kobs values of 443(10) s
-1 and 50(3) s-1 for the decay and return of the 
fluorescence, respectively.  While the rate of decay is similar to that observed for NDM-1 and L1, the 
rate of regaining fluorescence intensity is considerably more rapid in AIM-1 than in the other enzymes 
(i.e. ~50 s-1 vs ~5 s-1).  Furthermore, since the rate of product formation (see k2 for Model C in Table 
5.5) exceeds that of the decay of the intermediate (i.e. k3 for Models A and B) it appears that the 
mechanistic pathway via the observed intermediate is a possible albeit not an optimal route for 
substrate conversion for AIM-1.  In summary, it appears that AIM-1 is capable of facilitating two 
alternative variants of a mechanism to convert nitrocefin to its product, one that resembles the strategy 
employed by L1 and NDM-1 in which the protonation of the ring-opened reaction intermediate is 
rate-limiting, and one that resembles the mechanism used by Bla2, where the protonation of the 
intermediate is not rate-limiting (and hence the intermediate is not observed experimentally).  This 
interpretation may indicate distinct binding modes for the substrate in the active site and highlights a 
mechanistic flexibility available specifically to AIM-1. 
 
 
Figure 5.17: Pre-steady state stopped-flow fluorescence measurement recorded at room temperature under single turnover 
conditions (10 μM AIM-1 and 16 μM nitrocefin).  Two distinct transients are observed, an initial rapid quench followed 
by a more gradual regain of fluorescence intensity (the inset shows the residuals of the fitting process). 
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5.5 Discussion 
MBLs pose a considerable risk to global health, not least due to their broad substrate specificities, a 
reflection of structural plasticity in the vicinity of the catalytic centres of these enzymes.  This 
plasticity may (i) prove beneficial for MBLs to adapt their mechanisms rapidly to new challenges 
(i.e. novel β-lactam antibiotics) and also (ii) hinder the design of clinically promising universal MBL 
inhibitors that may be developed into drugs to combat antibiotic resistance (238).  The mechanistic 
diversity of MBLs is illustrated in a comparison between the enzyme Bla2 from B. anthracis and L1 
from S. maltophilia (128,233).  While Bla2 converts the substrate nitrocefin directly to its corresponding 
product (i.e. no intermediate is observed experimentally), L1 employs a mechanism whereby a metal 
ion-bound anionic intermediate is formed, the decay of which is the rate-limiting step of the reaction.  
Other MBLs, including NDM-1, CcrA from B. fragilis or BcII from B. subtilis appear to employ a 
mechanism similar to that of L1 (99,102,151,233,234).  Mechanistic diversity in MBLs is also observed 
when their catalytic properties are investigated at various pH values with a range of different 
substrates.  Specifically, it was observed that MIM-1 and MIM-2, two MBLs from environmental 
microorganisms, display distinctly different pH optima, with MIM-1 preferring high pH values and 
MIM-2 a more acidic environment (26,227).  Furthermore, catalytically relevant protonation equilibria 
for reactions carried out with representatives from three of the major β-lactam substrates (i.e. 
ampicillin, cefuroxime and biapenem) vary significantly, and each of these substrates also inhibits 
the reaction at sufficiently high concentrations.  These observations were interpreted in terms of 
variations with respect to substrate binding in the active sites of these enzymes and also in terms of 
the presence of a second, inhibitory binding site for the substrates (227). 
5.5.1 AIM-1 is inhibited by its substrates and displays substrate-dependent mechanistic 
variations.   
The steady-state catalytic parameters recorded for AIM-1 are consistent with the above interpretation.  
Similar to MIM-1, MIM-2 or CcrA, AIM-1 displays substrate inhibition (Figure 5.4).  Furthermore, 
pH affects catalysis in a substrate-dependent manner (Figure 5.6).  Interestingly, the behaviour of 
AIM-1 lies in between those of MIM-1 and MIM-2; while the hydrolysis of cephalosporin (i.e. 
cefuroxime) and carbapenam (i.e. meropenem) representatives are optimal at low pH (as observed 
for MIM-2) the reaction with ampicillin prefers high pH values (as observed for MIM-1).  For the 
reaction with meropenem and cefuroxime, the respective pKes2 values are 9.4 and 7.7 (Table 5.1).  
While an unambiguous assignment of pKa values in a complex environment such as the active site of 
an enzyme is rarely possible, the above values are consistent with a water molecule that is coordinated 
67 
 
to one of the metal ions in the catalytic site, i.e. Zn2 in Figure 5.3 (227,239,240).  In its deprotonated form, 
this water ligand would be likely to affect the catalytic rate, especially if it occupies a position that is 
needed for optimal substrate binding (due to reduced ligand exchange rates).  Since the deprotonation 
event leads to an increase in reactivity towards ampicillin the corresponding equilibrium (pKes1 ~ 6.9) 
is likely to be associated with a residue different from that ascribed to the reactions with the above 
substrates.  A possible candidate is a water molecule that bridges the two Zn2+ ions in the active site, 
the proposed nucleophile that initiates bond breakage (15,16,150,208). Since the corresponding slope in 
the pH profile is less than 1 the chemical step in the reaction with ampicillin is, at best, only partially 
rate-limiting.  The absence of the corresponding pKes1 in the reaction with cefuroxime and meropenem 
then, by analogy, indicates that here the chemical step (i.e. hydrolysis) is not contributing to the rate-
limiting step at all.  Thus, it is evident that different substrates interact in distinctly different modes 
with the active site leading to variations in the reaction mechanism.  This conclusion is further 
supported by the analysis of the effect of pH on the reaction with nitrocefin (Figure 5.6).  The 
observed behaviour appears to be a combination of those recorded for the other three substrates.  Both 
acidic (pKes1) and alkaline (pKes2) limbs are present and their corresponding protonation equilibria 
contribute to the rate-limiting step (with slopes approximating unity).  This interpretation is consistent 
with the rapid kinetics data (recorded at optimal pH) that indicate that the rate of substrate decay (i.e. 
k2 in Table 5.5) is similar to the steady-state rate constant (i.e. kcat) for this reaction (~200 s
-1 vs ~240 
s-1). 
 
The substrate-dependent catalytic behaviour discussed in the previous section highlights the 
mechanistic diversity and flexibility of MBLs.  The substrate-induced inhibition observed for some 
of the reactants (except nitrocefin) then suggests the presence of more than one binding site or mode 
for those reactants.  The possibility of two (or more) distinct binding sites of a substrate in the vicinity 
of the active centre of AIM-1 is also supported by the observed mixed-type inhibition by D-captopril 
(Figure 5.6).  Furthermore, the presence of multiple binding sites or modes for substrates is consistent 
with the concentration-dependent lag in catalysis observed for the reaction with biapenem at substrate 
concentrations above Km (Figure 5.5).  While it is currently not known why this behaviour is only 
observed with biapenem (a rather poor substrate for AIM-1, with kcat ~ 0.8 s
-1; Figure 5.5) the direct 
proportionality between substrate concentrations (in the range between 0.2 – 2 mM, i.e. above the Km 
value for biapenem) and the lag period indicates a first-order process whereby a catalytically non-
competent state may be populated at increasing substrate concentrations.  This state could be a non-
productive enzyme-substrate complex. 
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5.5.2 AIM-1 activity can be reconstituted with Co2+ but is inhibited by Cu2+.   
Metal ion replacement studies are frequently employed to probe the mechanism of metal ion-
dependent enzymes.  Here, we focussed mainly on Co2+ since (i) it is a convenient spectroscopic 
probe and (ii) it facilitates a comparison with Co2+-derivatives of other MBLs (i.e. L1, Bla2, NDM-
1) (102,128,233).  Similar to those MBLs AIM-1 is catalytically active in its Co2+-substituted form (vide 
supra).  To our knowledge there are no ITC data available for other MBLs that compare binding 
interactions of different metal ions.  Our analysis indicates that the apoform of AIM-1 binds two Zn2+ 
ions with comparable affinity (~170 nM; Figure 5.9 and Table 5.2), whereas it binds one Co2+ with 
high affinity (~7 nM) and a second with considerably weaker affinity (~2 μM).  A similar observation 
was previously reported for the B1-type MBLs BcII and Bla2; using spectrophotometric titrations it 
was shown that Co2+ binds with different affinities to the two binding sites in the active centre, 
although the difference appears to be no more than one order of magnitude (233,241). The affinity of the 
weaker bound Co2+ is similar to the Kd value of this metal ion determined for MIM-1 and MIM-2 by 
measuring the catalytic activity as a function of added Co2+ (227).  The observation of varying metal 
ion affinities for Co2+ thus indicates that a bimetallic centre needs to be formed in order to reconstitute 
an active form of AIM-1. 
 
According to the crystal structure of the Zn2+-derivative of AIM-1 (Figure 5.3) the two metal ions 
(i.e. Zn1 and Zn2) are four- and five-coordinate, respectively, and are connected via a water molecule 
(the likely nucleophile in the reaction).  Zn2 contains an additional water ligand and consequently it 
adopts a distorted trigonal bipyramid geometry, whereas Zn1 is tetrahedral.  In contrast, MCD and 
EPR data (Figures 5.11 and 5.13) indicate that both Co2+ ions are six-coordinate; it is likely that extra 
water molecules complement the octahedral arrangement of the two metal ions.  The change in 
geometry resulting from the metal ion replacement is consistent with variations in the observed Km 
for cefuroxime (i.e. ~20 μM vs 60 μM for the Zn2+- and Co2+-derivatives of AIM-1, respectively).  
Surprisingly, the interaction of the Co2+-derivative of AIM-1 with the inhibitor D-captopril does not 
lead to significant spectral changes (Figures 5.11 and 5.13).  This may suggest that the inhibitor does 
not bind directly to any of the metal ions in the active site, or coordinates via its carboxyl group to 
one or both metal ions.  This interpretation is in contrast to the available crystal structure of the 
complex between D-captopril and the MBL L1 (in its native Zn2+ form) that demonstrates that in that 
enzyme the thiol sulfur atom of the inhibitor displaces the bridging water ligand from the active site 
(76), but is in agreement with the mixed-type of inhibition observed for this compound (vide supra).   
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In contrast to Co2+, Cu2+ is not able to reconstitute activity of apoAIM-1.  Furthermore, a mixed-type 
of inhibition was observed when the effect of Cu2+ ions on native AIM-1 was probed (Figure 5.7).  
Since addition of Cu2+ to the metal-free apoform of AIM-1 did not reconstitute catalytic activity an 
uncompetitive mode of inhibition was expected, whereby the copper ions occupy the location of the 
Zn2+ ions in the catalytically active native form of the enzyme.  The competitive mode of inhibition 
by Cu2+ is more difficult to reconcile with a mechanistic explanation but may be indicative of an 
alternative binding site for Cu2+; upon binding of the metal to this site a conformational change may 
occur that prevents the substrate from binding to the active centre. The heat changes associated with 
Cu2+ titrations to both the apo and native forms of AIM-1 were too small to yield reliable estimates 
of the stoichiometry and affinity of bound Cu2+ (data not shown).  However, cwEPR data of a sample 
of apoAIM-1 following the addition of Cu2+ indicates that two metal ions in close vicinity are bound, 
as evidenced by their strong antiferromagnetic coupling (i.e. the resulting spectrum is EPR-silent; 
Figure 5.15).  This interpretation is in agreement with a study of MIM-1 and MIM-2 that demonstrated 
that close to two Cu2+ binds to tthose enzymes (227).  However, in contrast to AIM-1 the Cu2+-
derivatives of those enzymes are catalytically still active.  These observations are thus another 
illustration of the mechanistic versatility inherent to MBLs.  Independent of the precise mechanism 
of Cu2+-promoted inhibition of AIM-1, the observation that this metal ion interferes with the activity 
of this enzyme raises the possibility that antibiotic-resistant pathogens expressing particular MBLs 
(such as AIM-1) may return to their sensitive state in presence of Cu2+.  
5.5.3 Substrate positioning may affect the rate of the AIM-1-catalysed hydrolysis of the 
substrate nitrocefin.   
The above discussion highlights the fact that the active site of AIM-1 is versatile with respect to 
binding substrates and inhibitors, and that there may be more than one binding mode and/or locus for 
these reactants.  This flexibility is also reflected in the reaction mechanism employed by this enzyme.  
Current mechanistic models for dinuclear MBLs are exemplified by Bla2 and L1/NDM-1, 
respectively (102,128,233).  Specifically, for the reaction with the substrate nitrocefin Bla2 catalyses a 
direct, one-step conversion of the substrate to product, whereas a two-step mechanism is operational 
in L1 and NDM-1, whereby a ring-opened anionic intermediate is formed.  The decay of this 
intermediate is the rate-limiting step in the reaction.  In each of the MBLs compared the rate of 
fluorescence quenching is two- to threefold more rapid than the rate of substrate consumption (in the 
case of AIM-1 the corresponding rates are ~450 s-1 vs ~200 s-1; vide supra).  This indicates that 
initially a catalytically non-competent ES complex is formed that is then transformed into an active 
Michaelis complex.  From that point onward a variation is observed between L1/NDM-1 (with an 
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observed reaction intermediate) and Bla2 (no observed intermediate), a variation that may be 
associated with the protonation rate of the anionic intermediate(99,102,128,233); in L1 and NDM-1 this 
protonation is rate-limiting, in Bla2 it is not.  Insofar, AIM-1 appears to be unique in that both options 
appear to be operational (Figure 5.16).  Thus, while in NDM-1, L1 and Bla2 nitrocefin may be 
positioned in a distinct conformation relative to the donor source of the proton (possibly a histidine 
residue in the active site), in AIM-1 the substrate may be bound in more than one orientation (hence 
affecting the rate of proton transfer).  In the absence of a crystal structure with bound nitrocefin the 
precise position of these alternative binding modes remain obscure, however their existence may yet 
be another demonstration of the structural plasticity inherent to MBLs that may allow these enzymes 
to adapt rapidly to an ever increasing number of antibiotics.  In this context it is also interesting to 
point out that a recent study with the MBLs BcII and VIM-2, two representatives from subgroup B1, 
indicated that metal ion composition may also affect the precise mechanism employed by these 
enzymes.  In their native Zn2+-form BcII behaves like Bla2 (i.e. no reaction intermediate observed), 
whereas VIM-2 resembles NDM-1 and L1 with an intermediate observable at 665 nm(242). Upon 
replacement of Zn2+ by Fe2+ an intermediate is observed only in BcII.  Hence, MBLs have indeed the 
ability to alter/adapt their mechanism of action, an observation which will have a profound effect on 
the design of potent and persisting inhibitors. 
5.6 Conclusion 
A major aim of current medicinal chemistry is to develop a universal inhibitor for MBLs as a strategy 
to combat antibiotic resistance.  So far limited success has been achieved, largely due to differences 
in active site geometries and the resulting variations in substrate specificities, metal ion 
stoichiometry’s and reaction mechanisms.  AIM-1 may serve as a paradigm to illustrate these 
variations, facilitating the binding of substrates in different modes and/or sites, some catalytically 
competent, others inhibitory.  Furthermore, in alignment with these different binding modes the 
enzyme may also employ mechanistic variations to convert substrates into products.  As pointed out 
in an earlier study residue Gln157, unique in AIM-1 among known MBLs, may play an important 
role in mediating interactions with both the substrate and product (216).  While the precise origin of 
the mechanistic flexibility observed specifically for AIM-1 remains obscure it places this enzyme in 
an ideal position as a crucial target to identify or develop potentially universal MBL inhibitors.  The 
search for inhibitors that bind to the enzyme under different conditions (i.e. different pH, different 
metal ion composition) may facilitate the design of compounds that are not easily rendered ineffective 
by small alterations in the substrate binding pocket.  Furthermore, since AIM-1 encompasses 
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functional elements common for many MBLs such compounds may prove successful against most of 
the commonly targeted MBLs.  In addition, at least for AIM-1, the observed inhibition by Cu2+ may 
provide an alternative avenue to devise strategies to reduce the impact of this enzyme on antibiotic 
resistance.  As a step towards the design of leads it is now essential to obtain crystal structures of 
Co2+- and Cu2+-derivatives of AIM-1, in free form as well as in complex with D-captopril and, for 
the latter, in presence of substrates.  Steps towards these aims are currently in progress. 
5.7 Experimental Section 
5.7.1 Materials  
The AIM::pJ411 was cloned into the commercial vector (DNA 2.0). Escherichia coli BL21 (DE3) 
cells used for protein expression were purchased from New England BioLabs.  All chemicals used, 
unless stated otherwise, were purchased from Sigma-Aldrich. 
5.7.2 Recombinant expression and purification:  
Wild-type AIM-1 was expressed and purified using a modified protocol of a previously published 
procedure (216).  In brief, BL21 (DE3) cells were transformed with the AIM-1-encoding plasmid 
PJ411.  Cells were then grown in LB medium (containing 50 µg/ml kanamycin) at 37 °C until the 
OD600 reached 0.4-0.6.  AIM-1 expression was induced by adding 50 µg/ml IPTG and lowering the 
temperature to 18 °C.  The culture was then grown for another 48 hours. 
 
The following steps for the protein purification were performed at 4 °C.  Cells were harvested by 
centrifugation at 5000 rpm and then re-suspended in 20 mM HEPES buffer, 0.15 mM ZnCl2, pH 7.5, 
accompanied with 60 mg of lysozyme and 30 mg protease inhibitor (EDTA-free) Roche.  The cells 
were then lysed by sonication using five 30-second bursts of 60% maximum output power, and the 
supernatant was loaded onto a Hitrap Q FF 5 ml column.  A linear NaCl gradient (0-1 M) was applied 
to elute proteins over two column volumes.  Fractions containing activity against ampicillin were 
combined, concentrated and subsequently loaded onto a Hiprep 16-60 sephacryl S-300 HR gel 
filtration column, previously equilibrated with 20 mM HEPES buffer, 0.15 mM ZnCl2, pH 7.2.  
Purified AIM-1 was stored in 10% glycerol at -20 °C.  The protein concentration was determined by 
measuring the absorption at 280 nm (ε = 38,305 M-1cm-1 per monomer).  An average purification 
yields approximately 1.5 mg of protein per litre of cell culture medium. 
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5.7.3 Generation of the Co2+ derivative:  
The metal ion-free form of AIM-1 was prepared by incubation of 0.10 mg/mL of enzyme with 5 mM 
EDTA in 20 mM HEPES buffer (pH 7.0).  The enzyme solution was allowed to stand for 24 hours at 
4 °C.  The chelating agent was then removed using an Econo-Pac 10DG (Bio-Rad) desalting column, 
previously treated with 20 mM buffer HEPES buffer, pH 7.2.  The enzyme was then incubated with 
100-fold excess of the desired metal ion (i.e. Co2+) for 24 hours at 4 °C. 
5.7.4 Steady-state catalytic assays:  
Steady-state kinetic assays were performed at 25 °C using a Cary 50 Bio Varian UV-Vis 
spectrophotometer.  The hydrolysis of cefuroxime (ε235nm = 9,320 M-1cm-1), biapenem (ε293nm = 7,600 
M-1cm-1), ampicillin (ε235 nm= 820 M-1cm-1), nitrocefin (ε485nm = 17,400 M-1cm-1) and meropenem 
(ε300nm = 6,500M-1cm-1) was monitored by detecting the degradation of the substrate at the indicated 
wavelengths.  The pH of the assays ranged from 5.5 to 10 and was adjusted using a multi-component 
buffer system which included 100 mM acetate, 100 mM MES, 100 mM HEPES, 100 mM CHES and 
100 mM CAPS.  Catalytic rates were measured as a function of the substrate concentration.  The data 
was analysed by non-linear regression (Prism 6 software) using either the standard Michaelis-Menten 
equation (i.e. Equation 5.1) or a modified equation that takes into account the binding of a second 
substrate molecule to an inhibitory site (Equation 5.2) (228): 
 
Equation 5.1    v =
𝑉𝑚𝑎𝑥.𝑆
𝐾𝑀+S
 
 
Equation 5.2    v =
𝑉𝑚𝑎𝑥.𝑆
(𝐾𝑀+S(1+
𝑆
𝐾𝑖
))
 
 
 
In these equations v and Vmax represent the measured and limiting rate, respectively.  S is the substrate 
concentration while KM and Ki represent the Michaelis and substrate inhibition constants, 
respectively.  The pH dependence of kcat and kcat/Km were analysed by fitting respective data to 
equations derived for mono- or diprotic systems (i.e. Equations 5.3 and 5.4, respectively), where H 
represents the proton concentration, K is the acid dissociation constant, and c is the pH independent 
value of y (i.e. kcat) 
(228,243) 
73 
 
 
 
Equation 5.3   Log (y) =
𝑐
1+
𝐻
𝐾
      
 
Equation 5.4   Log (y) =
𝑉(1+
𝐾2
𝐻
)
1+(
𝐻
𝐾1
)+(
𝐾2
𝐻
)
 
 
Inhibition assays were conducted in the same manner as described above with the exception that 
increasing amounts of an inhibitor (i.e. captopril, Cu2+) were added.  The assays were performed in 
20 mM HEPES buffer, pH 7.5, using the substrate cefuroxime.  The enzyme concentration was 2.7 
nM, and the inhibitor concentration ranged from 0 - 800 µM.  The data were fitted to a general 
inhibition equation that allows for both a competitive and uncompetitive mode of inhibitor binding 
(Equation 5.5) (228).  Kic and Kiuc represent the inhibitor dissociation constants for competitive and 
uncompetitive binding, respectively. 
 
 
Equation 5.5    𝑉 =
𝑉[𝑆]
𝐾𝑚(1+
[𝐼]
𝐾𝑖𝑐
) + (1+ 
[𝐼]
𝐾𝑖𝑢
)[𝑆]   
      
 
5.7.5 Isothermal titration calorimetery:  
The binding affinity and stoichiometry of Zn2+ and Co2+ for AIM-1 were determined by isothermal 
titration calorimetry (ITC).  The experiments were performed with an ITC200 instrument from 
Microcal.  The reaction cell was filled with 33 µM apoenzyme in 20 mM HEPES buffer, pH 7.5, 
under constant stirring at 1000 rpm at 25 °C.  A solution of 5 mM of the desired metal ion was then 
titrated into the reaction cell, with a spacing of 60 s between injections to allow the heat in the cell to 
return to the baseline.  The data were analysed using MicroCal Origin 7.0 software using an approach 
described elsewhere (195,231).  The heat released during each injection was fitted to an equation that 
was derived from a model including two individual binding sites (195,231).   
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5.7.6 Stopped flow UV-Vis and fluorescence measurements:  
Stopped-flow kinetic measurements in both the absorbance and fluorescence mode were performed 
on an Applied Photophysics SX20 Stopped-Flow spectrophotometer equipped with a photodiode 
array and fluorometer detector.  All experiments were carried out in Chelex-treated 20 mM HEPES 
buffer, pH 7.5, at 25 °C.  Data were recorded using nitrocefin as the substrate under single turn-over 
conditions (i.e. final concentrations before triggering the reaction were 16 μM AIM-1 and 20 μM 
nitrocefin).  The transients observed in the fluorescence measurements were analysed by fitting them 
to first order exponential equations included in the Applied Photophysics software package.  The 
absorbance data were converted into concentrations using 1 cm as cell path length and the extinction 
coefficients for nitrocefin (ε390nm = 11,500 M-1cm-1), its product (ε485nm = 17,420 M-1cm-1) and a 
previously observed reaction intermediate (ε665nm = 32,000 M-1cm-1) (99,102,128,233,244).  The data were 
simulated using KIMSIM software and fitted using FITSIM (235,236,245).  The models used for fitting 
are shown in Figure 5.16.  
5.7.7 Magnetic circular dichroism:  
The Co2+ derivative of AIM-1 was prepared as described above.  The excess of Co2+ was removed 
using a desalting column, pre-equilibrated with 50 mM Tris.HCl buffer, pH 8.0.  The derivative was 
then diluted with glycerol to a final concentration of 60%/40% (v/v) glycerol/buffer.  The final protein 
concentration in the samples used to record magnetic circular dichroism (MCD) spectra was ~0.7 
mM.  The sample was placed into a 0.62 cm path length nickel-plated copper sample cell with quartz 
windows.  Data were acquired with a JASCO J815 spectropolarimeter, equipped with an Oxford 
Instruments SM4000 cryostat/magnet.  Standard spectra were measured at 7.0 T and 1.3 K.  Variable-
temperature, variable-field (VTVH) MCD data were collected at increments of 0.5 T from 0 to 7.0 T 
and at temperatures of 1.4, 3, 6, 12, 24 and 48 K.  The final spectra were converted to wavenumbers 
and fitted to a minimum number of Gaussian peaks to achieve the final composite spectrum using 
GRAMS AI software package.  The data were analysed as described elsewhere (22,218-220,229-232). 
5.7.8 Electron paramagnetic resonance spectroscopy:  
Low temperature X-Band EPR spectra were recorded on a Bruker Elexys E600 EPR spectrometer 
equipped with an Oxford Instruments ESR900 helium flow cryostat.  Spectra were recorded at 9.64 
GHz (B0  B1) and 9.38 GHz (B0 B1) using an ER4116DM dual-mode cavity, with 10 G (1 mT) 
magnetic field modulation at 100 kHz.  Spin Hamiltonian parameters were estimated from computer 
simulations carried out using XSophe (Bruker Biospin), assuming H0 = βB0gŜ/ħ+ ŜDŜ, where S = 
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3/2, D >> βgBS/ħ, and where D > 0 implies the MS = ±1/2 Kramers doublet lies lowest and all 
observed EPR transitions are from this doublet, and D < 0 implies the MS = ±3/2 Kramers doublet lie 
lowest and all observed EPR transitions are from this doublet. 
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Chapter 6  
Comparison of the active site structures of several BMHs using 
magnetic circular dichroism (MCD) 
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6.1 Abstract: 
Magnetic circular dichroism (MCD) is a technique that can provide information about the 
coordination environment of metal ions within proteins. Importantly, MCD may provide insight into 
the in-solution active site structure of a metalloenzymes when artefacts in the corresponding solid-
state structure are suspected due to the crystallisation process. In previous chapters it was 
demonstrated that BMHs with rather diverse functions (i.e. phosphatases and MBLs) employ similar 
mechanistic strategies for their reactions. Here, we expand this analysis to compare the active site 
structures of several BMHs by MCD. One of these enzymes is LRA-8, identified in a microbial 
community in the remote and frozen environment of Alaska. LRA-8 has a substrate profile and 
catalytic properties similar to well-known MBLs, despite emerging from an environment that has 
been subjected to minimal human interference. Also included are MIM-1 and MIM-2 (who’s crystal 
structures were discussed in Chapter 4), two enzymes with potent MBL activity despite originating 
from marine microorganisms that would have experienced minimal exposure to anthropogenic 
pollution. Furthermore, MIM-1 and MIM-2 have also been shown to be potent lactonases. This 
comparative study also included CpsB from Streptococcus pneumoniae, a phosphatase that has 
become a promising target for the development of novel chemotherapeutics to combat antibiotic 
resistance. As a suitable paramagnetic probe for MCD studies Co2+ was employed. Despite 
considerable functional differences between the four enzymes, an analysis of their coordination 
environment by MCD demonstrates that the immediate active site geometry in these enzymes is rather 
similar, thus demonstrating that a common active site motif is capable of supporting a diverse range 
of catalytic reactions. 
6.2 Introduction 
Magnetic circular dichroism (MCD) provides a convenient avenue to probe the structure and function 
of metalloenzymes by spectroscopic techniques. In particular, MCD has been demonstrated to be 
useful in structure/function studies of a range of BMH (see Chapter 5 for an example) (1,246-252) and 
provides insights into the geometric and electronic structure of these systems in solution. MCD is 
valuable as both supportive information for other spectroscopic techniques and may be used to 
provide structural information in cases where crystal structures are not available. 
 
MCD arises from the difference in absorption between left and right circularly polarised light (A = 
A(-) – A(+))  by a sample positioned within a strong magnetic field that is orientated parallel to the 
emitted light source. While CD requires an optically active sample and relies on structural features 
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(chirality) to distribute the electronic charge, MCD arises purely from the electromagnetic 
interactions between the charges within the sample and the externally applied field. Furthermore, the 
A in the MCD results from a magnetic perturbation of the electronic states involved in the absorption 
transition by the Zeeman effect, defined by the magnetic optical rotation observed when a plane of 
linear polarized light is rotated in a collinear magnetic field in terms of B and C leading to Equation 
6.1 (253,254). 
 
Equation 6.1   
∆𝐴
𝐸
= 𝛾𝛽𝐻 [𝐴1 (
−𝜕𝑓(𝐸)
𝜕𝐸
) + (𝐵0 + 
𝐶0
𝜅𝑇
) 𝑓(𝐸)] 
 
Equation 6.1 is derived from the “Born-Oppenheimer” approximation, where 𝑓(𝐸) is the linear shape 
of the function of the energy. It describes the observed Franck-Condon envelope of the absorption 
band. The A, B and C terms are quite complex, involving the electric and magnetic dipole operator 
matrix elements with the particular electronic state involved in the transitions, and will be discussed 
below. 
 
The A-terms arise when excited state degeneracy occurs (i.e. the allowed atomic transitions from the 
allowed 1S01P-1,0,+1 include 0  +1 and 0  -1). In the absence of a magnetic field the absorption 
bands for the polarized light AL and AR coincide and A = 0. Under an applied magnetic field, the 
excited state of 1Pj levels split with energy given by the following relation: E = g (Zeeman 
splitting). If g is positive 1P-1 level will be the lowest and the A will be negative. For higher energies 
1S01P+1 and A will be positive. 
 
The B-terms arise from a mixing of the applied magnetic field with the zero-field wave-functions, 
where both the excited and the ground state wave-functions can be affected. In these cases, the 
degeneracy can be removed by placing the paramagnetic centre (e.g. Co2+) in a low symmetry 
environment (i.e. enzyme ligands), in which, the angular momentum is “quenched” by low symmetry 
field imposed by the bound ligands. 
 
The C-terms are similar to the A-terms with the exception that the degeneracy is in the ground state. 
Consequently, the transition is strongly temperature-dependent. In this chapter, I will focus on 
enzyme samples whose active sites contain reconstituted bimetallic Co2+ centres. Apart from being 
paramagnetic, Co2+-reconstituted metal ion centres have been studied for a number of BMHs and 
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related model complexes, and thus they provide a well-studied platform for structural comparisons 
(23,144,254-258).  
 
Co2+ displays coordination flexibility, encompassing the ability to form octahedral, tetrahedral, 
square pyramidal, trigonal bipyramidal and trigonal prismatic complexes (259). This coordination 
flexibility makes Co2+ particularly useful for analysing the electronic structures of active sites within 
metalloenzymes. Relevant to this study, MCD allows for the simple distinction between five- and six-
coordinate Co2+ centres in metallo-systems of interest. Five-coordinate Co2+ species with N and O 
ligands typically have multiple negative MCD bands between 650 and 450 nm, with a maximum 
around 550 nm (±30 nm). In contrast, six-coordinate Co2+ with similar ligands have a sharp and 
intense negative MCD band at 500 nm (±15 nm), which is often split in low symmetry environments 
(254). The general shape and intensities of these MCD bands are typically conserved for both 
monomeric and dimeric active sites, as demonstrated in recently reported MCD investigations of a 
series of model complexes (72,144,258,260-265). Variable temperature, variable field (VTVH) MCD data 
provide, apart from zero-field splitting parameters of the cobalt species, also insight into the exchange 
coupling in a dimeric centre (254). 
 
In this Chapter MCD spectroscopy was employed to garner mechanistic and structural insights of 
various BMHs. CpsB (a phosphatase) represents an interesting case where the available crystal 
structure information suggests the presence of a third metal weakly bound in the active site, a result 
conflicting with metal ion binding data (266) (associated publication A). MIM-1 and MIM-2 
(previously introduced in Chapter 4) have been shown by crystallography to have an active site 
structure very similar to that of the B3-subgroup MBL AIM-1 (introduced in Chapter 5); however, in 
contrast to AIM-1 MIM-1 and MIM-2 originate from environmental, non-pathogenic microorganism 
and possess an alternative function in form of lactonase activity (26). Similar to the two MIM proteins, 
LRA-8, described in more detail below, originates from a non-pathogenic microbial environment, the 
permanently frozen tundra in Alaska. Previous studies (associated publication B) have demonstrated 
that this enzyme is indeed a potent MBL, and in absence of crystallographic data we investigated its 
active site structure with MCD.  
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6.3 Materials and methods 
6.3.1 Materials:  
All chemicals used, unless stated otherwise, were purchased from Sigma-Aldrich. Escherichia coli 
BL21 (DE3) cells used for protein expression of MIM-1, MIM-2 and LRA-8 were purchased from 
New England BioLabs.  Similarly, E. coli LEMO21(DE3) host cells purchased from New England 
BioLabs were used for the protein expression of CpsB. 
6.3.2 Expression and purification of CpsB 
CpsB(SP0347; TIGR4)  cloned under the control of a pBAD promoter  (pWQ553) was transformed 
into E. coli Lemo21(DE3) for expression via heat shock. The cells were then grown in LB medium 
containing ampicillin (50 µg/mL) and chloramphenicol (30 µg/mL) at 37 °C until the OD600 reached 
0.4-0.6.  Recombinant protein expression was induced by adding L-arabinose (0.1 % m/v) whilst 
maintaining the incubation temperature at 30 °C with constant shaking (200 rpm) for 24 h.  
 
The following steps for the protein purification were performed at 4 °C.  Cells were harvested by 
centrifugation and lysed using a French press (1000 psi). The CpsB construct contains an N-terminal 
hexahistidine tag allowing purification of the soluble fraction via a Ni2+ affinity column (Ni2+-IMAC 
resin), equilibrated with buffer containing 50 mM Tris HCl, pH 8.5, 5 mM of mercaptoethanol, 150 
mM sodium chloride and 20 mM imidazole.  
 
The protein was eluted with an isocratic gradient utilising the previous buffer solution with increased 
concentration of imidazole (200 mM) and 10% glycerol. The final protein concentration was 
measured via UV at 280 nm using ε280 = 20400 M-1.cm-1 (monomeric unit). Approximately 30mg of 
purified protein were recovered per litre of LB medium. 
6.3.3 Expression of MIM-1, MIM-2 and LRA-8 
MIM-1, MIM-2 and LRA-8 were expressed and purified using a previously published procedure (137). 
E. coli BL21 (DE3) cells were transformed with the plasmid PJ411 (containing encoding genes for 
each enzyme, respectively) via heat shock. PJ411 plasmids were purchased from DNA 2.0. Cells 
were then grown in LB medium (containing 50 µg/ml kanamycin) at 37 °C until the OD600 reached 
0.4-0.6.  Recombinant protein expression was induced by adding 50 µg/ml IPTG and reducing the 
incubating temperature to 18 °C for 48 hours with shaking (200 rpm). 
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6.3.4 Purification of MIM-1 and MIM-2 
The following steps for the protein purification were performed at 4 °C and were detailed in Chapter 
4.  E. coli cells were harvested by centrifugation at 5000 rpm and then re-suspended in 20 mM Hepes 
buffer, 0.15 mM ZnCl2, pH 7.5.  60 mg of lysozyme and 30 mg protease inhibitor (EDTA-free) were 
added to the protein solution with stirring for 20 minutes.  The cells were then lysed by sonication 
using five 30-second bursts of 60% maximum output power, and the supernatant was loaded onto a 
Hitrap Q FF 5 ml column.  A linear NaCl gradient (0-1 M) was applied to elute proteins over two 
column volumes.   
 
Fractions containing activity against cefuroxime were combined, concentrated and subsequently 
loaded onto a Hiprep 16-60 sephacryl S-300 HR gel filtration column, previously equilibrated with 
50 mM TRIS buffer, 0.15 mM ZnCl2, pH 7.2.  Purified protein was stored in 10% glycerol at -20 °C.  
Protein concentration was determined via UV at 280 nm (ε = 36,815 M-1cm-1 and 41,285 M-1cm-1 per 
monomer for MIM-1 and MIM 2 respectively).  The polypeptide was recovered without the 
periplasmic sequence attached and yielded roughly 5mg of protein per litre of LB medium. 
6.3.5 Purification of LRA-8 
The following steps for the protein purification were performed at 4 °C.  Cells were harvested by 
centrifugation at 5000 rpm and then re-suspended in 50 mM Tris.HCl, pH 8.5, 5 mM β-
mercaptoethanol, 150 mM NaCl buffer. 1 mg/mL protease inhibitor (ETDA free) and 60 mg 
lysozyme were added with stirring for 20 minutes and then the cells were lysed via sonication.  
 
The LRA-8 construct also contained an N-terminal hexa-histidine tag allowing for initial purification 
of the supernatant on a 25 mL HiTrapQ FF Ni2+ affinity column (Ni2+-IMAC resin; GE Healthcare), 
equilibrated with 50 mM Tris.HCl buffer, pH 8.5, containing 150 mM NaCl, 5 mM β-
mercaptoethanol and 20 mM imidazole.  The protein was eluted with an isocratic gradient utilising 
the previous buffer solution with increased concentration of imidazole (500 mM) and 10% glycerol.  
 
Fractions containing MBL activity were combined, concentrated and further purified via loading onto 
a Hiprep 16-60 sephacryl S-300 HR gel filtration column, previously equilibrated with 50 mM 
Tris.HCL buffer, pH 8.5, 0.2 M NaCl and 0.15 mM ZnCl2. The final protein concentration was 
measured via UV at 280 nm using ε280 = 42315 M-1.cm-1 (monomeric unit). An average expression 
resulted in a yield of 12 mg of purified LRA-8 per litre of LB medium.   
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6.3.6 MCD spectroscopy 
Prior to recording MCD data Co2+ derivatives of each of the protein samples had to be prepared. The 
preparation of the apo-enzyme was performed following a previously published procedure (267-269) by 
adding 10 mM EDTA in 20 mM Hepes buffer, pH 7.0, to the purified enzyme (CpsB, MIM-1, MIM-
2 and LRA8).  After 24 h incubation at 4 °C the chelating agent was removed using a desalting column 
(Econo-Pac 10DG from Bio-Rad) that was equilibrated with 20 mM Hepes buffer, pH 7.0.  
Subsequently, three equivalents of Co2+ were added to the metal-free protein solution and the mixture 
was incubated over night at 4 °C.  The excess of Co2+ was removed using a desalting column pre-
equilibrated with 50 mM Tris.HCl buffer, pH 8.0.  
 
For spectroscopic measurements this solution was diluted with glycerol to a final concentration of ~ 
0.7 mM (i.e. a 3:2 glycerol:buffer mixture).  The samples were transferred to a 0.62 cm path length 
nickel-plated copper sample cell with quartz windows.  The MCD system used has a JASCO J815 
spectropolarimeter and an Oxford Instruments SM4000 cryostat/magnet.  Data were initially 
collected at 7.0 T and 1.4 K.  Variable-temperature, variable-field (VTVH) data were measured at 
increments of 0.5 T from 0 to 7.0 T and at temperatures of 1.4, 3, 6, and 12, 24 and 48K.  The 
experimental spectra were plotted as a function of wavenumbers and fitted to a minimum number of 
Gaussian peaks to achieve the final composite spectrum using the GRAMS AI software package.  The 
data were subsequently analysed as described in detail elsewhere (268-274). 
6.4 Results and discussion 
6.4.1 Active site structure of CpsB 
CpsB is a metal-dependent protein tyrosine phosphatase that belongs to the polymerase and histidinol 
phosphatase (PHP) enzyme family, whose metal ion composition remains ambiguous (275,276). 
Reported crystal structures for CpsB suggest three Mn2+ ions (M1, M2 and M3 in Figure  6.1) are 
prevalent in the active site (52). The electron density suggests that the third metal ion (M3) might be 
weakly bound due to its lower occupancy. Although uncommon, catalytic active sites possessing 
more than two metal ion have been seen before for some metallohydrolases (231).  
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Figure 6.1: Metal binding site of CpsB (stereo pair). Residues that interact with metal ions M1, M2 and M3 (purple 
spheres) are shown. The water ligands W1, W2 and W3 are depicted as red spheres. 
  
In terms of the reaction mechanism it has been proposed that the catalytic cycle in CpsB involves an 
esterolysis-initiating hydroxide nucleophile that is doubly Lewis-activated by coordination to M1 and 
M2. This is similar to related phosphotriesterases (5), MBLs (15,206), ureases(14) arginases (238) and some 
PAPs (161).  The presence of the third metal ion within the active site was proposed to play an important 
role in substrate recognition (52). 
 
In order to probe the active site of CpsB the MCD spectrum of the Co2+-derivative of the enzyme was 
recorded; the resulting spectrum could be fitted to no fewer than seven transitions between 400 to 600 
nm (Fig. 6.2; Table 6.1).  Calculations using the angular overlap model (AOM) were used to assign 
the individual transitions as described in detail elsewhere.(229) The coordinates for the calculations 
were taken from the crystal structure (PDB code 2WJE) and each metal site was treated separately.  
The calculations indicate that the seven transitions are linked to the presence a six-coordinate (6C) 
and a five-coordinate (5C) Co2+ species, similar to what was observed for the glycerophosphate 
diesterase GpdQ.(220,273)   
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Figure 6.2: MCD spectrum (7 T, 1.4 K) of CpsB at pH 8.5 (top) and fitted VTVH MCD data (bottom) for the transitions 
observed at 492, 502 and 525 nm.  Temperatures of red, green, blue, yellow, grey, black represent data collected at 1.4, 
3.0, 6.0, 12.0, 24.0 and 48.0 K, respectively 
 
The VTVH MCD data for each of the seven transitions were extracted and assessed for quality; only 
those bands which gave rise to high-quality data (i.e. those at 492, 502, and 520 nm) were selected 
for fitting, using the dimer model (Figure 6.2; Table 6.2).(229) Based on its energy and fitted electronic 
parameter (D  50 cm-1), the transition at 492 nm arises from the 4T1g 4T1g(P) transition in the 
parent Oh symmetry of a high-spin 6C Co
2+ ion. The structure is distorted, causing the 6C peak to 
split into two bands (i.e. 461 and 492 nm).  The two small peaks at higher energy (i.e. 411 and 428 
nm) are due to spin-forbidden doublet transitions in this Co2+ species, whose energies are enhanced 
through spin-orbit coupling.  The VTVH MCD analysis of the 492 nm band indicates that the 
corresponding cobalt species is exchange-coupled (J = 0.12 cm-1) to a 5C Co2+ associated with both 
the 502 nm and the 520 nm transitions (both of which have identical electronic structural parameters; 
Table 6.2).  This assignment is also supported by the VTVH MCD analysis of the 502 and 520 nm 
bands, resulting in a D = 7.7 cm-1 (Table 6.2), a value typical for 5C Co2+ species.(229) Similar to 
the MBL AIM-1 (Chapter 5) the dimetallic Co2+ centre in CpsB is thus weakly ferromagnetically 
400 450 500 550 600
-500
-400
-300
-200
-100
0
Wavelength (nm)
m
 d
eg
 (
m
M
-1
)
0.0 0.5 1.0 1.5
0.0
0.5
1.0
bH/2kT
N
o
rm
a
li
ze
d
 I
n
te
n
si
ty
492 nm
0.0 0.5 1.0 1.5
0.0
0.5
1.0
bH/2kT
N
o
rm
a
li
ze
d
 I
n
te
n
si
ty
502 nm
0.0 0.5 1.0 1.5
0.0
0.5
1.0
bH/2kT
N
o
rm
a
li
ze
d
 I
n
te
n
si
ty
525 nm
85 
 
coupled.(201,277) The AOM calculations also support the assignment of the 565 nm transition to a 5C 
cobalt.   
 
Table 6.1: Summary of ligand field calculations* 
Species Origin in Oh or D3h d-d transition (nm) 
Observed Calculated 
- Co2+ 
(B = 890,  = 3,020) 
4T1g 2T1g(G) 411 406 
4T1g 2T1g(G) 428 429 
4T1g 4T1g(P) 461 450 
4T1g 4T1g(P) 492 483 
- Co2+ 
(B = 710,  = 4,030) 
4A2 2E``(P) 520 535 
4A2 4 A2 (P) 565 560 
 
These values correspond to transitions arising from a 6C, α, and a 5C, β, species. The Racah parameter 
C was fitted according to C = 4.6B.  The units for B, C and  are cm-1 
 
Table 6.2: Spectroscopic parameters obtained from fitting VTVH MCD data using the dimer model. 
Parameter 492 nm 502 nm 520 
nm 
J (cm-1) 0.12 0.11 0.11 
D (6C) (cm-1) ≥ 50 ≥ 50 ≥ 50 
D (5C) (cm-1) 6.28 7.7 7.7 
E (α, β metal) (cm-1) 0 0 0 
 
Interestingly, the catalytically active Co2+-reconstituted CpsB does not provide and spectroscopic 
evidence of a third metal ion, indicating that the binding of the third metal ion (coordinated to Glu108, 
His136, Glu80 and W2 in Figure 6.1) may in fact be a crystallographic artefact only, and does not 
represent the enzyme active site in solution.  
6.4.2 Active site structures of MBL-like proteins from environmental microorganisms 
Antibiotic resistance is rapidly increasing with an increasing number of organisms displaying the 
ability to produce β–lactamases, and hence resist commonly used β-lactam antibiotics. The number 
of MBL-like proteins identified through functional metagenomics studies is rising in parallel to 
increasing antimicrobial resistance in bacteria generally. The distribution of these enzymes within 
soil and water samples appears to be widespread ranging from densely populated areas to the remote 
wilderness of uninhabited places. The prevalence of MBL-like enzymes that can confer resistance to 
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enzymes is alarming, and adds complexity to the fight against antimicrobial resistance globally. 
Examples of such enzymes include MIM-1 from N. pentaromativorans, MIM-2 from S. agarivorans 
(both discussed in Chapter 4) and LRA-8, identified among several -Lactam Resistance in Alaskan 
soil genes, respectively (26,136).  
 
Kinetically, the MIM enzymes are proficient Penicillinases, with MIM-1 typically preferring alkaline 
conditions whilst MIM-2 prefers acidic conditions (26). Similarly, LRA-8 confers resistance towards 
various cephalosporin- and penicillin-type antibiotics (see Chapter 6, associated publication B). The 
MIM proteins in particular have been shownto be functionally promiscuous; In addition to their MBL 
activity they are efficient lactonases (most similar to N-acylhomoserine lactonases(26)). MIM-1 
appears to be the first of this class of enzymes to be catalytically efficient with Ca ions as cofactors 
(26). 
 
Crystallographic investigations of the two MIM proteins were reported in Chapter 4. The enzyme are 
most similar to B3-type MBLs, containing a dimetallic Zn2+ active site. The metal ion ligands are 
His116, His118 and His196, and Asp120, Cis221 and His263 for the Zn1 and Zn2 ions, respectively 
(identical to the ligands of AIM-1; see Chapter 5). The two metal ions are bridged by a water 
molecule, whilst a second water is terminally coordinated to Zn2. No crystal structure of LRA-8 is 
yet available. However, based on sequence homology it was expected that LRA-8 would have an 
active site highly similar to that of B3-type MBLs (Figure 6.3).   
 
Figure 6.3: : Active site of a typical B3-type MBL (reference structure: AIM-1 (PDB 4AWY).(216,278)  
The native Zn2+ ions could easily be replaced with paramagnetic  Co2+, and similar to other MBLs, 
the replacement of Zn2+ by Co2+ leads to an active form of these enzymes with moderately reduced  
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catalytic activity, a slight impact on substrate binding and reduced competitive inhibitory effect of D-
captropril (26).  Irrespective of the catalytic changes, MIM-1, MIM-2 and LRA-8 were suitable 
candidates for spectroscopic investigation via our previously mentioned and reported methodology.  
 
 
 
Figure 6.4: Gaussian-resolved MCD spectra (7 T, 1.4 K) of the B3-type MBLs from environmental microorganisms; 
MIM-1 (top left), MIM-2 (top right) and LRA-8 (bottom).  
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Figure 6.5: Examples of VTVH MCD data with corresponding fits for the transitions observed at 491 and 503 nm in 
MIM-1. Points coloured red, green, blue, yellow, grey, black represent data collected at 1.4, 3.0, 6.0, 12.0, 24.0 and 48.0 
K, respectively. 
 
 
The MCD spectra for the MIM proteins and LRA-8 required five and four Gaussians to resolve the 
spectra between 400-600 nm, respectively (Figure 6.4; Table 6.3).  
 
Calculations using AOM were used to assign these transitions, and VTVH MCD data associated with 
these transitions were extracted and analysed using the dimer model as described elsewhere (270). 
Relevant fitting parameters are summarised in Table 6.4. 
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Table 6.3: Summary of ligand field calculations 
 Origin in Oh d-d transition (nm) 
  Observed Calculated 
MIM-1    
 
 
𝑇1𝑔 → 𝑇1𝑔(𝐺) 
2
 
4  463 469 
𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  490 487 
𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  507 503 
𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  520 512 
 𝑇1𝑔 → 𝐴2𝑔 
4
 
4  565 559 
MIM-2    
 
 
𝑇1𝑔 → 𝑇1𝑔(𝐺) 
2
 
4  470 465 
𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  490 490 
𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  505 506 
𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  517 518 
 𝑇1𝑔 → 𝐴2𝑔 
4
 
4  567 566 
LRA-8    
 𝑇1𝑔 → 𝑇1𝑔(𝐺) 
2
 
4  464 460 
 𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  491 495 
 𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  502 503 
 𝑇1𝑔 → 𝑇1𝑔(𝑃) 
4
 
4  509 517 
    
 
Table 6.4: Spectroscopic parameters obtained from fitting VTVH MCD data using the dimer model. 
  MIM-1   MIM-2  LRA-8 
Parameter 463 nm                       490 nm 507 nm 470 nm 490 nm 505 nm 464 nm 491 nm 509 nm 
J (cm-1) 0.29 0.27 0.26 0.31 0.27 0.27 0.29 0.31 0.27 
D (6-coordinate)  
(cm-1) 
≥ 50 ≥ 50 ≥ 50 ≥ 50 ≥ 50 ≥ 50 ≥ 50  ≥ 50  ≥ 50 
D (6-coordinate)  
(cm-1) 
- - - - - - -  - - 
E (α,β metal)  (cm-1) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
 
The major transitions in MIM-1, MIM-2 and LRA-8 are 490/520 nm, 490/517 nm and 491/509 nm, 
respectively, and arise from spin-allowed 
4
T
1g
(P) transitions associated with a six-coordinate Co2+ 
ions in the active site.    Importantly, fitting the VTVH MCD data of the major resolved transitions 
in all three protein samples indicates that in each case two six-coordinate Co2+ ions are weakly 
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ferromagnetically exchange-coupled (J ~ 0.2 cm-1). Insofar, MIM-1, MIM-2 and LRA-8 have an 
active site electronic structure that is very similar to that of the B3-type MBL AIM-1 (269).   
6.5 Conclusion  
In the present study spectroscopic properties of the metalloenzymes CpsB, MIM-1, MIM-2 and LRA-
8 with a view to (i) gaining insights into their metal ion centres and (ii) comparing these properties 
with other members of the large family of BMHs were investigated using MCD. 
 
Collectively, while the present study establishes a similar dimetallic metal ion centre in CpsB, LRA-
8, MIM-1 and MIM-2, it also highlights some of the disparity in metal binding that may exist between 
crystallographic (solid state) studies and ‘in solution’ investigations. According to available crystal 
structures for CpsB, the active site of this enzyme was proposed to be a trinuclear Mn2+ centre, 
whereby two of the closely spaced metal ions activate a water molecule for a nucleophilic attack on 
the phosphate moiety of a substrate.  The third metal ion was proposed to be involved in substrate 
binding.(52) However, MCD data have demonstrated that active CpsB contains only a dimetallic metal 
centre in solution. This is supported by recently published atomic absorption measurements of Mn2+ 
or Co2+-reconstituted CpsB and ITC data, which also indicate the presence of only two bound metal 
ions in the active enzyme(266).  The metal ion affinities, determined by ITC, are similar to those of the 
well-characterised antibiotic-degrading MBL AIM-1 (72)  (see also Chapter 5) and cyclic nucleotide 
diesterases,(257) but significantly weaker than those recorded for phosphotriesterases.(232)  To date the 
in vivo metal ion composition of CpsB remains obscure, but Mn2+ appears to be the most likely 
candidate, based on optimal catalytic performance combined with bioavailability.   
 
Recent crystallographic investigations of MIM-1 and MIM-2 (presented in chapter 4) indicate that 
the native Zn2+-bound enzymes contain a five- and a six-coordinate metal ion in the active site, linked 
via a µ-OH which is believed to be the nucleophile for hydrolysis. In contrast, MCD data of the Co2+-
substituted derivatives suggest the presence of two six-coordinate metal centres, an observation also 
seen for the homologous AIM-1 (Chapter 5). It is reasonable to attribute the additional ligand to the 
presence of an additional, terminally coordinated water molecule. The observed variation in 
coordination number may be a reflection of different coordination chemical properties of zinc and 
cobalt ions, or it may be caused as a consequence of a crystallographic artefact. However, considering 
the fact that the catalytic properties of the Co2+-derivatives of MIM-1, MIM-2, LRA-8 and AIM-1 
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are similar to those of their Zn2+-containing counterparts it is likely that the variation in the 
coordination number has little effect on the function of these enzymes.  
 
For LRA-8 no crystallographic data are available for comparison. Hence, the spectroscopic data 
presented here provide a first insight into the active site of this enzyme, and they demonstrate that 
LRA-8 is likely to have an active site structure and catalytic mechanism characteristic for MBLs.   
 
Thus, while spectroscopic studies demonstrate that several BMHs that may differ in function, at the 
molecular level they operate in a rather conserved manner.  However, it needs to be remembered that 
in order to carry out this comparison Co2+ derivatives of each of these enzymes were generated.  Since 
cobalt is not the native metal ion in any of these enzymes the question remains how metal ion 
selectivity may affect the function of these enzymes. We know already that MIM-1 and MIM-2 
operate optimally as MBLs when Zn2+ is bound, but Ca2+ promotes their lactonase activity.(26)  
Furthermore, different metal ions may affect the immediate geometry of the coordination 
environment in different ways as evidenced by the significant variations in entropy observed when 
different metal ions bind to a particular active site(268,279). Thus, while my studies demonstrate that 
under identical conditions diverse enzyme from the BMH superfamily may operate in a conserved 
manner, the question as to how metal ion selectivity (and thus function) may be modulated remains 
to be solved.  
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Chapter 7 
Conclusions and direction for further work 
 
This thesis has examined the kinetic, structural, spectroscopic and mechanistic features of several 
BMHs that share similarities in their active site geometry, yet differ in their associated primary 
functions.   
 
In Chapter 2 the reaction trajectory, including the transition state, of the PAP-catalysed reaction were 
investigated. Specifically, the averaged geometry of two alternate conformations for bound 
phosphate, a product and substrate mimic, represented a good model for the structure of the transition 
state. The high-resolution crystal structure of this complex also highlighted a hydrogen bond between 
the metal ion bridging µ-OH and an oxygen atom of the bound phosphate group. This observation 
indicates that at least in this complex the µ-OH does not act as the reaction-initiating nucleophile but 
instead assist the binding and orientation of the substrate and transition state during the catalytic cycle. 
Given the similarity in the active site between this enzyme and numerous other BMHs, it is likely 
that a similar transition state may be present in all these enzymes. Hence, the structural insight gained 
here may be exploited in the design of transition state mimics as leads of future chemotherapeutics, 
targeted against various ailments associated with BMHs.  
 
Chapter 3 provided insights into the high resolution (1.3 Å) structure for fluoride-inhibited OpdA, 
and discussed the significance of an extensive hydrogen bonding network for the mechanism 
employed by this enzyme. Specifically, the structure shows two alternative conformations of several 
residues in the substrate binding pocket when the fluoride-bound and free form of OpdA were 
compared. Interestingly, although the structural changes imposed on the first coordination sphere by 
fluoride binding to the two metal ions is small, their effect on the outer sphere is significant. In 
contrast, in the homologous enzyme OPH, which has a first coordination sphere identical to that of 
OpdA, fluoride does not act as an inhibitor, most likely because in this enzyme no extensive hydrogen 
bonding network is present that connects the metal ion binding site with the substrate binding pocket. 
It is currently unclear how minimal structural changes in the first coordination sphere are capable of 
imposing a significant effect on catalysis in OpdA. Computational studies combining density 
functional approaches with molecular dynamics calculations may provide essential insight into this 
fine-tuning mechanism. 
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In Chapter 4 the crystal structures of two novel, non-pathogenic MBL-like proteins from marine 
environments are described (i.e. MIM-1 and MIM-2). Although functionally different from the 
phosphatases described in the preceding Chapters, these enzymes share structrual simialrities that 
include the presence of a binuclear active site, whose metal ions are bridged by a water/OH molecule 
(the expected nucleophile for hydrolysis). While produced in an environment remote from direct 
human influence, MIM-1 and MIM-2 were shown to be structurally very similar to membes of the 
B3 subgroup of MBLs. Being non-pathogenic in origin yet sharing structural and mechanistic features 
with pathogenic MBLs, the MIM proteins are particularly interesting for continued efforts toward 
inhibitor developments. The fact that these enzymes have also displayed functional promiscuity in 
the form of lactonase activity, suggests that further structural investigations of substrate binding may 
lead to a greater understanding of the origins and evolution of MBL activity.  
 
In Chapter 5 a comprehensive kinetic and spectroscopic investigation of the pathogenic B3 subgroup 
MBL AIM-1 from Pseudomonas aeruginosa was presented. This enzyme is of particular clinical 
importance and our research has provided information on this enzyme’s mechanistic flexibility. 
Specifically, AIM-1 was shown to be capable of employing two alternative mechanistic strategies, 
likely to be due to a certain degree of freedom in binding the substrate. This observation may be 
useful in the design of potent inhibitors as binding flexibility may be taken into account to generate 
a group of compounds that bind reliably and persistently. 
 
Towards this aim, our group has commenced in synthesising a group of inhibitors as leads towards 
future drug design. Specifically, I tested several compounds produced by A/Prof. Ross McGeary’s 
group for their in vitro inhibitory effect on AIM-1 (Figure 7.1 and Table 7.1; see also paper recently 
published by EJMECH; https://doi.org/10.1016/j.ejmech.2017.05.061). The inhibitors were quite 
efficient with Ki values in the low μM range. The dominating mode of inhibition is competitive, 
although several compounds have a considerable contribution from an uncompetitive binding mode. 
This observation is in agreement with the mechanistic flexibility observed for AIM-1. 
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Table 7.1: Inhibition data for selected inhibitors of AIM-1 
Inhibitor AIM-1  
Kic (M) Kiuc (M) 
68 9.3± 2.2 30.19 ± 9.89 
70 10.85 ± 2.71 47.31 ± 13 
72 2.24 ± 0.33 12.48 ± 2.16 
39 2.27 ± 0.34 12.31 ± 2.11 
67 3.04 ± 0.86 9.79 ± 2.44 
30 3.04 ± 0.86 9.79 ± 2.44 
 
 
 
 
Figure 7.1: Structures of inhibitors tested on AIM-1 
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Current efforts in the group focus thus on obtaining crystal structures of AIM-1 in complex with some 
of these inhibitors. Some preliminary crystals are shown in Figures 7.2 and 7.3 although to date, no 
reasonable diffraction data have been obtained.  
 
 
Figure 7.2: Selected crystals for AIM-1 co-crystallised with the inhibitor captopril. Associated crystallisation screens and 
well conditions include: peg rx-G6 (left), peg ion-H8 (centre), peg ion-A5 (right).  
 
 
Figure 7.3: Selected crystals for AIM-1 co-crystallised with inhibitor 70. Associated crystallisation screens and well 
conditions include: peg ion-D5 (left), peg ion-H8 (centre), peg ion-H4 (right). 
 
In Chapter 6 ‘in solution’ metal ion coordination investigations of several BMHs were discussed. The 
method of choice was MCD, largely because it provides a simple approach towards gaining insight 
into the active site structure of Co2+ derivatives ofthese enzymes. Apart from providing functional 
insight such studies may also demonstrate how ligand binding (i.e. inhibitors or substrates) affects 
the active site structure, thus providing guidance in the development or improvement of antagonists 
that may inform the development of potent future drug leads. My investigations demonstrated, 
however, that the non-clinical inhibitor D-captopril does not appear to perturb the electronic structure 
of the di-Co2+ centre, suggesting that it may not bind directly to the metal ions. This is in contrast to 
available crystal structures of MBLs with bound D-captopril, which demonstrate that the inhibitor 
binds to both metal ions via its thiol group. This potential differences in lignad binding may point to 
a crystallographic artefact, and it is thus prudent to analyse inhibitor binding with a range of available 
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techniques. Similarly, my spectroscopic data demonstrated that CpsB, a promising target for novel 
antimicrobial agents, is indeed a BMH; the third metal ion observed in the active site of the 
crystallised enzyme is also likely to be a crystallographic artefact. 
 
Studies like the ones on MIM-1 and MIM-2 (Chapters 4 and 6) or LRA-8 (Chapter 6) are interesting 
since they provide functional insight on novel enzymes that may be of relevance for the development 
of chemotherapeutics although their host organisms are not immediately pathogenic. I thus extended 
this approach to search for other MBL-like proteins and identified an MBL homolog in Salmonella 
typhimurium (i.e. SIM-1). I successfully expressed this enzyme in E.coli and purified it following the 
same procedure outlined for LRA-8 in Chapter 6. The purified enzyme was used in crystallisation 
trials and some crystals were obtained (Figure 7.4). No suitable diffraction data have yet been 
collected. I also collected preliminary MCD data for the Co2+-substituted variant of SIM-1 (Figure 
7.5). While data collection is not yet complete an initial analysis of the spectral data indicates that the 
active site contains two six-coordinate Co2+ ions similar to other MBLs (as discussed in Chapters 5 
and 6). Future efforts will continue toward completing this investigation, defining SIM-1 as a novel 
target to combat antibiotic resistance in S. typhimurium. 
 
Thus, to conclude, this thesis presented an in-depth analysis of the active site structure and mechanism 
of a range of related BMH, and the insight gained may be instrumental for future developments of 
inhibitors that can be introduced as lead treatments for a range of human ailments. 
 
Figure 7.4: Selected crystals of the putative B3 subgroup MBL SIM-1. 
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Figure 7.5: Gaussian-resolved MCD spectrum of SIM-1 at 7 T and 1.4 K. 
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Appendix A 
 
 
Multiple sequence alignment including MBLs AIM-1, MIM-1, MIM-2, SMB-1, L1, BJP, FEZ-1 and 
RM3. Sequences were extracted from the protein data bank and were aligned using online software 
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). The alignment was then manipulated 
using online software ESPript3 (http://espript.ibcp.fr/ESPript/ESPript/).  
 
Highly conserved residues are highlighted in red whilst homologous regions are surrounded by blue 
boxes. Secondary structure features for MIM-2 are shown above the alignment, whilst secondary 
structure features for AIM-1 are shown below the alignment for comparison.  
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